tcga_bcr.patient.FISH_test_component_results.FISH_test_component_result.FISH_test_component.@cde.64527
tcga_bcr.patient.FISH_test_component_results.FISH_test_component_result.FISH_test_component_percentage_value.@cde.3151691
tcga_bcr.patient.ablations.ablation.ablation_treatments.ablation_performed_indicator.@cde.3225709
tcga_bcr.patient.ablations.ablation.ablation_treatments.ablation_treatment.ablation_type.@cde.3225702
tcga_bcr.patient.ablations.ablation.ablation_treatments.ablation_treatment.ablation_type_other.@cde.3225705
tcga_bcr.patient.ablations.ablation.ablation_treatments.ablation_treatment.days_to_ablation_performed.@cde.5043518
tcga_bcr.patient.ablations.ablation.ablation_treatments.ablation_treatment.lesions_count.@cde.3225710
tcga_bcr.patient.ablations.ablation.ablation_treatments.ablation_treatment.treatment_cycles_count.@cde.2199
tcga_bcr.patient.ablations.ablation.bcr_ablation_uuid.@cde.
tcga_bcr.patient.ablations.ablation.day_of_form_completion.@cde.2975716
tcga_bcr.patient.ablations.ablation.embolization_treatments.embolization_performed_indicator.@cde.3225713
tcga_bcr.patient.ablations.ablation.embolization_treatments.embolization_treatment.days_to_embolization_performed.@cde.5043521
tcga_bcr.patient.ablations.ablation.embolization_treatments.embolization_treatment.embolization_therapy_drug_name.@cde.3225736
tcga_bcr.patient.ablations.ablation.embolization_treatments.embolization_treatment.embolization_therapy_drug_name_other.@cde.2975232
tcga_bcr.patient.ablations.ablation.embolization_treatments.embolization_treatment.embolization_type.@cde.3225722
tcga_bcr.patient.ablations.ablation.embolization_treatments.embolization_treatment.embolizing_agent_utilized.@cde.3247288
tcga_bcr.patient.ablations.ablation.embolization_treatments.embolization_treatment.embolizing_agent_utilized_other.@cde.3225739
tcga_bcr.patient.ablations.ablation.month_of_form_completion.@cde.2975718
tcga_bcr.patient.ablations.ablation.year_of_form_completion.@cde.2975720
tcga_bcr.patient.acute_myeloid_leukemia_calgb_cytogenetics_risk_category.@cde.3121502
tcga_bcr.patient.adenocarcinoma_invasion.@cde.3027106
tcga_bcr.patient.adjacent_hepatic_tissue_inflammation_extent_type.@cde.3173974
tcga_bcr.patient.age_at_initial_pathologic_diagnosis.@cde.2006657
tcga_bcr.patient.age_began_smoking_in_years.@cde.2178045
tcga_bcr.patient.albumin_result_lower_limit.@cde.2004085
tcga_bcr.patient.albumin_result_specified_value.@cde.58274
tcga_bcr.patient.albumin_result_upper_limit.@cde.2004086
tcga_bcr.patient.alcohol_history_documented.@cde.2201918
tcga_bcr.patient.alcoholic_exposure_category.@cde.3457767
tcga_bcr.patient.aln_pos_ihc.@cde.3151831
tcga_bcr.patient.aln_pos_light_micro.@cde.3151832
tcga_bcr.patient.amount_of_alcohol_consumption_per_day.@cde.3124961
tcga_bcr.patient.anatomic_neoplasm_subdivision.@cde.3108203
tcga_bcr.patient.anatomic_neoplasm_subdivision_other.@cde.2584114
tcga_bcr.patient.anatomic_neoplasm_subdivisions.anatomic_neoplasm_subdivision.@cde.3108203
tcga_bcr.patient.animal_insect_allergy_history.@cde.3121314
tcga_bcr.patient.animal_insect_allergy_types.@cde.3121316
tcga_bcr.patient.antireflux_treatment.@cde.3203107
tcga_bcr.patient.antireflux_treatment_types.antireflux_treatment_type.@cde.3440206
tcga_bcr.patient.asbestos_exposure_age.@cde.3629991
tcga_bcr.patient.asbestos_exposure_age_last.@cde.3629993
tcga_bcr.patient.asbestos_exposure_source.@cde.3629990
tcga_bcr.patient.asbestos_exposure_type.@cde.3629989
tcga_bcr.patient.asbestos_exposure_years.@cde.3629992
tcga_bcr.patient.assessment_timepoint_category.@cde.3151756
tcga_bcr.patient.asthma_history.@cde.3133921
tcga_bcr.patient.atra_exposure.@cde.2625735
tcga_bcr.patient.axillary_lymph_node_stage_method_type.@cde.2516112
tcga_bcr.patient.axillary_lymph_node_stage_other_method_descriptive_text.@cde.3124496
tcga_bcr.patient.barretts_esophagus.@cde.3440212
tcga_bcr.patient.bcr_patient_barcode.@cde.2003301
tcga_bcr.patient.bcr_patient_barcode.@cde.2673794
tcga_bcr.patient.bcr_patient_uuid.@cde.
tcga_bcr.patient.bilirubin_lower_limit.@cde.2718241
tcga_bcr.patient.bilirubin_upper_limit.@cde.2003891
tcga_bcr.patient.biochemical_recurrence.@cde.3351904
tcga_bcr.patient.birth_control_pill_history_usage_category.@cde.3104217
tcga_bcr.patient.bladder_carcinoma_extracapsular_extension_status.@cde.3130374
tcga_bcr.patient.blood_relative_cancer_history_list.blood_relative_cancer_history.cancer_diagnosis_cancer_type_icd9_text_name.@cde.2195089
tcga_bcr.patient.blood_relative_cancer_history_list.blood_relative_cancer_history.family_cancer_type_txt.@cde.3813653
tcga_bcr.patient.blood_relative_cancer_history_list.blood_relative_cancer_history.family_history_cancer_type.@cde.3838107
tcga_bcr.patient.blood_relative_cancer_history_list.blood_relative_cancer_history.family_history_cancer_type_other.@cde.3813653
tcga_bcr.patient.blood_relative_cancer_history_list.blood_relative_cancer_history.family_member_relationship_type.@cde.2783641
tcga_bcr.patient.blood_relative_cancer_history_list.blood_relative_cancer_history.relative_family_cancer_hx_text.@cde.3613444
tcga_bcr.patient.bone_scan_results.@cde.3351888
tcga_bcr.patient.braf_gene_analysis_performed.@cde.3123151
tcga_bcr.patient.braf_gene_analysis_result.@cde.3107189
tcga_bcr.patient.braf_gene_genotyping_outcome_lab_results_text.@cde.3179257
tcga_bcr.patient.breast_cancer_surgery_margin_status.@cde.2241252
tcga_bcr.patient.breast_carcinoma_estrogen_receptor_status.@cde.2957359
tcga_bcr.patient.breast_carcinoma_immunohistochemistry_er_pos_finding_scale.@cde.3203081
tcga_bcr.patient.breast_carcinoma_immunohistochemistry_pos_cell_score.@cde.3133874
tcga_bcr.patient.breast_carcinoma_immunohistochemistry_progesterone_receptor_pos_finding_scale.@cde.3203083
tcga_bcr.patient.breast_carcinoma_primary_surgical_procedure_name.@cde.1218
tcga_bcr.patient.breast_carcinoma_progesterone_receptor_status.@cde.2957357
tcga_bcr.patient.breast_carcinoma_surgical_procedure_name.@cde.2739580
tcga_bcr.patient.breast_neoplasm_other_surgical_procedure_descriptive_text.@cde.3124493
tcga_bcr.patient.breslow_depth_value.@cde.2593055
tcga_bcr.patient.cancer_first_degree_relative.@cde.3171640
tcga_bcr.patient.cervical_carcinoma_corpus_uteri_involvement_indicator.@cde.3151610
tcga_bcr.patient.cervical_carcinoma_pelvic_extension_text.@cde.3151605
tcga_bcr.patient.cervical_neoplasm_pathologic_margin_involved_text.@cde.3151544
tcga_bcr.patient.cervical_neoplasm_pathologic_margin_involved_type.@cde.3151541
tcga_bcr.patient.chemical_exposure_text.@cde.2596673
tcga_bcr.patient.child_pugh_classification_grade.@cde.2931791
tcga_bcr.patient.circumferential_resection_margin.@cde.64202
tcga_bcr.patient.city_of_procurement.@cde.3203075
tcga_bcr.patient.colon_polyps_present.@cde.64184
tcga_bcr.patient.colorectal_cancer.@cde.2684753
tcga_bcr.patient.country_of_birth.@cde.2183279
tcga_bcr.patient.country_of_procurement.@cde.3203072
tcga_bcr.patient.creatinine_lower_level.@cde.2634934
tcga_bcr.patient.creatinine_upper_limit.@cde.2183392
tcga_bcr.patient.creatinine_value_in_mg_dl.@cde.2655822
tcga_bcr.patient.cumulative_agent_total_dose.@cde.1515
tcga_bcr.patient.cytogenetic_abnormalities.cytogenetic_abnormality.@cde.2760451
tcga_bcr.patient.cytogenetic_abnormality_other.@cde.2957553
tcga_bcr.patient.cytogenetic_analysis_performed_ind.@cde.2626417
tcga_bcr.patient.cytokeratin_immunohistochemistry_staining_method_micrometastasis_indicator.@cde.3086152
tcga_bcr.patient.day_of_form_completion.@cde.2975716
tcga_bcr.patient.days_from_date_of_initial_pathologic_diagnosis_to_date_of_birth.@cde.3008233
tcga_bcr.patient.days_to_birth.@cde.3008233
tcga_bcr.patient.days_to_bone_scan_performed.@cde.3412936
tcga_bcr.patient.days_to_death.@cde.3165475
tcga_bcr.patient.days_to_diabetes_onset.@cde.3457768
tcga_bcr.patient.days_to_diagnostic_computed_tomography_performed.@cde.3414503
tcga_bcr.patient.days_to_diagnostic_mri_performed.@cde.3414554
tcga_bcr.patient.days_to_fdg_or_ct_pet_performed.@cde.5654367
tcga_bcr.patient.days_to_first_biochemical_recurrence.@cde.3414609
tcga_bcr.patient.days_to_initial_pathologic_diagnosis.@cde.3008275
tcga_bcr.patient.days_to_initial_pathologic_diagnosis.@cde.3131740
tcga_bcr.patient.days_to_laboratory_procedure_tumor_marker_squamous_cell_carcinoma_antigen_result.@cde.5654374
tcga_bcr.patient.days_to_last_followup.@cde.3008273
tcga_bcr.patient.days_to_last_known_alive.@cde.
tcga_bcr.patient.days_to_last_known_alive.@cde.3131740
tcga_bcr.patient.days_to_pancreatitis_onset.@cde.3457771
tcga_bcr.patient.days_to_performance_status_assessment.@cde.3479270
tcga_bcr.patient.days_to_submitted_specimen_dx.@cde.3430945
tcga_bcr.patient.death_cause_text.@cde.2004150
tcga_bcr.patient.diabetes.@cde.2716085
tcga_bcr.patient.diagnosis.@cde.3081932
tcga_bcr.patient.diagnosis_subtype.@cde.2783887
tcga_bcr.patient.diagnostic_ct_abd_pelvis_performed.@cde.3194099
tcga_bcr.patient.diagnostic_ct_abd_pelvis_results.diagnostic_ct_abd_pelvis_result.@cde.3351890
tcga_bcr.patient.diagnostic_ct_result_outcomes.diagnostic_ct_result_outcome.@cde.3151439
tcga_bcr.patient.diagnostic_mri_performed.@cde.3607491
tcga_bcr.patient.diagnostic_mri_result_outcomes.diagnostic_mri_result_outcome.@cde.3151441
tcga_bcr.patient.diagnostic_mri_results.diagnostic_mri_result.@cde.3351891
tcga_bcr.patient.disease_detection_molecular_analysis_method_type.@cde.3121575
tcga_bcr.patient.disease_detection_molecular_analysis_method_type_other_text.@cde.3151694
tcga_bcr.patient.disease_extracapsular_extension_ind-3.@cde.64165
tcga_bcr.patient.distant_metastasis_anatomic_site.@cde.2961431
tcga_bcr.patient.distant_metastasis_present_ind2.@cde.2194698
tcga_bcr.patient.dlco_predictive_percent.@cde.2180255
tcga_bcr.patient.drugs.drug.bcr_drug_uuid.@cde.
tcga_bcr.patient.drugs.drug.clinical_trail_drug_classification.@cde.3378323
tcga_bcr.patient.drugs.drug.day_of_form_completion.@cde.2975716
tcga_bcr.patient.drugs.drug.days_to_drug_therapy_end.@cde.3392470
tcga_bcr.patient.drugs.drug.days_to_drug_therapy_start.@cde.3392465
tcga_bcr.patient.drugs.drug.days_to_stem_cell_transplantation.@cde.3414613
tcga_bcr.patient.drugs.drug.drug_name.@cde.2975232
tcga_bcr.patient.drugs.drug.measure_of_response.@cde.2857291
tcga_bcr.patient.drugs.drug.month_of_form_completion.@cde.2975718
tcga_bcr.patient.drugs.drug.number_cycles.@cde.62590
tcga_bcr.patient.drugs.drug.pharm_regimen.@cde.3366758
tcga_bcr.patient.drugs.drug.pharm_regimen_other.@cde.3366930
tcga_bcr.patient.drugs.drug.prescribed_dose.@cde.2184728
tcga_bcr.patient.drugs.drug.prescribed_dose_units.@cde.3065815
tcga_bcr.patient.drugs.drug.regimen_indication.@cde.2793511
tcga_bcr.patient.drugs.drug.regimen_indication_notes.@cde.2793516
tcga_bcr.patient.drugs.drug.regimen_number.@cde.2673845
tcga_bcr.patient.drugs.drug.regimen_number.@cde.2744948
tcga_bcr.patient.drugs.drug.route_of_administrations.route_of_administration.@cde.2003586
tcga_bcr.patient.drugs.drug.stem_cell_transplantation.@cde.3090688
tcga_bcr.patient.drugs.drug.stem_cell_transplantation_type.@cde.2730901
tcga_bcr.patient.drugs.drug.therapy_ongoing.@cde.3103479
tcga_bcr.patient.drugs.drug.therapy_types.therapy_type.@cde.2793530
tcga_bcr.patient.drugs.drug.therapy_types.therapy_type_notes.@cde.2001762
tcga_bcr.patient.drugs.drug.total_dose.@cde.1515
tcga_bcr.patient.drugs.drug.total_dose_units.@cde.3088785
tcga_bcr.patient.drugs.drug.tx_on_clinical_trial.@cde.3925111
tcga_bcr.patient.drugs.drug.year_of_form_completion.@cde.2975720
tcga_bcr.patient.eastern_cancer_oncology_group.@cde.88
tcga_bcr.patient.ectopic_pregnancy_count.@cde.2261915
tcga_bcr.patient.eczema_history.@cde.3133925
tcga_bcr.patient.egfr_amplication_status.@cde.3124957
tcga_bcr.patient.egfr_mutation_identified.@cde.4588601
tcga_bcr.patient.egfr_mutation_performed.@cde.3139429
tcga_bcr.patient.egfr_mutation_result.@cde.3147627
tcga_bcr.patient.eml4_alk_translocation_identified.@cde.4588602
tcga_bcr.patient.eml4_alk_translocation_method.@cde.3139449
tcga_bcr.patient.eml4_alk_translocation_performed.@cde.3139437
tcga_bcr.patient.eml4_alk_translocation_result.@cde.3139445
tcga_bcr.patient.er_detection_method_text.@cde.69
tcga_bcr.patient.er_level_cell_percentage_category.@cde.3128341
tcga_bcr.patient.erythrocyte_sedimentation_rate_result.@cde.3104952
tcga_bcr.patient.ethnicity.@cde.2192217
tcga_bcr.patient.extrathyroid_carcinoma_present_extension_status.@cde.3179452
tcga_bcr.patient.eye_color.@cde.3870394
tcga_bcr.patient.family_history_of_cancer.@cde.2436860
tcga_bcr.patient.family_history_of_primary_brain_tumor.@cde.3133957
tcga_bcr.patient.family_history_of_stomach_cancer.@cde.3203179
tcga_bcr.patient.family_history_other_cancer.@cde.3901752
tcga_bcr.patient.family_history_testicular_cancer.@cde.3896777
tcga_bcr.patient.fdg_or_ct_pet_performed_outcomes.fdg_or_ct_pet_performed_outcome.@cde.3151497
tcga_bcr.patient.female_breast_feeding_or_pregnancy_status_indicator.@cde.3012573
tcga_bcr.patient.fetoprotein_outcome_lower_limit.@cde.3171861
tcga_bcr.patient.fetoprotein_outcome_upper_limit.@cde.2932064
tcga_bcr.patient.fetoprotein_outcome_value.@cde.2932074
tcga_bcr.patient.fibrosis_ishak_score.@cde.3182621
tcga_bcr.patient.first_degree_relative_history_thyroid_gland_carcinoma_diagnosis_relationship_types.first_degree_relative_history_thyroid_gland_carcinoma_diagnosis_relationship_type.@cde.3179002
tcga_bcr.patient.first_diagnosis_age_asth_ecz_hay_fev_mold_dust.@cde.3121273
tcga_bcr.patient.first_diagnosis_age_of_animal_insect_allergy.@cde.3121318
tcga_bcr.patient.first_diagnosis_age_of_food_allergy.@cde.3121301
tcga_bcr.patient.first_nonlymph_node_metastasis_anatomic_sites.metastatic_site_at_diagnosis.@cde.3124499
tcga_bcr.patient.first_nonlymph_node_metastasis_anatomic_sites.metastatic_site_at_diagnosis_other.@cde.3124503
tcga_bcr.patient.first_presenting_symptom.@cde.3133911
tcga_bcr.patient.first_presenting_symptom_longest_duration.@cde.3121001
tcga_bcr.patient.fish_evaluation_performed_ind.@cde.64521
tcga_bcr.patient.fluorescence_in_situ_hybrid_cytogenetics_metaphase_nucleus_result_count.@cde.64523
tcga_bcr.patient.fluorescence_in_situ_hybridization_abnormal_result_indicator.@cde.3121563
tcga_bcr.patient.fluorescence_in_situ_hybridization_diagnostic_procedure_chromosome_17_signal_result_range.@cde.3104295
tcga_bcr.patient.follow_ups.follow_up.additional_pharmaceutical_therapy.@cde.3427616
tcga_bcr.patient.follow_ups.follow_up.additional_radiation_therapy.@cde.3427615
tcga_bcr.patient.follow_ups.follow_up.additional_surgery_locoregional_procedure.@cde.3008755
tcga_bcr.patient.follow_ups.follow_up.additional_surgery_metastatic_procedure.@cde.3008757
tcga_bcr.patient.follow_ups.follow_up.additional_treatment_completion_success_outcome.@cde.3033278
tcga_bcr.patient.follow_ups.follow_up.adjuvant_rad_therapy_prior_admin.@cde.2308
tcga_bcr.patient.follow_ups.follow_up.agent_total_dose_count.@cde.2180805
tcga_bcr.patient.follow_ups.follow_up.assessment_timepoint_category.@cde.3151756
tcga_bcr.patient.follow_ups.follow_up.bcr_followup_barcode.@cde.
tcga_bcr.patient.follow_ups.follow_up.bcr_followup_uuid.@cde.
tcga_bcr.patient.follow_ups.follow_up.birth_control_pill_history_usage_category.@cde.3104217
tcga_bcr.patient.follow_ups.follow_up.brachytherapy_administered_status.@cde.3151103
tcga_bcr.patient.follow_ups.follow_up.brachytherapy_first_reference_point_administered_total_dose.@cde.3151100
tcga_bcr.patient.follow_ups.follow_up.brachytherapy_method_other_specify_text.@cde.3150976
tcga_bcr.patient.follow_ups.follow_up.brachytherapy_method_type.@cde.2966127
tcga_bcr.patient.follow_ups.follow_up.breast_carcinoma_estrogen_receptor_status.@cde.2957359
tcga_bcr.patient.follow_ups.follow_up.breast_carcinoma_immunohistochemistry_pos_cell_score.@cde.3133874
tcga_bcr.patient.follow_ups.follow_up.breast_carcinoma_progesterone_receptor_status.@cde.2957357
tcga_bcr.patient.follow_ups.follow_up.chemotherapy_regimen_types.chemotherapy_regimen_type.@cde.2007212
tcga_bcr.patient.follow_ups.follow_up.colorectal_cancer.@cde.2684753
tcga_bcr.patient.follow_ups.follow_up.concurrent_chemotherapy_dose.@cde.3166172
tcga_bcr.patient.follow_ups.follow_up.day_of_form_completion.@cde.2975716
tcga_bcr.patient.follow_ups.follow_up.days_to_additional_surgery_locoregional_procedure.@cde.3408572
tcga_bcr.patient.follow_ups.follow_up.days_to_additional_surgery_metastatic_procedure.@cde.3408682
tcga_bcr.patient.follow_ups.follow_up.days_to_brachytherapy_begin_occurrence.@cde.
tcga_bcr.patient.follow_ups.follow_up.days_to_brachytherapy_end_occurrence.@cde.
tcga_bcr.patient.follow_ups.follow_up.days_to_chemotherapy_end.@cde.
tcga_bcr.patient.follow_ups.follow_up.days_to_chemotherapy_start.@cde.
tcga_bcr.patient.follow_ups.follow_up.days_to_completion_of_curative_tx.@cde.
tcga_bcr.patient.follow_ups.follow_up.days_to_death.@cde.3165475
tcga_bcr.patient.follow_ups.follow_up.days_to_first_biochemical_recurrence.@cde.3414609
tcga_bcr.patient.follow_ups.follow_up.days_to_hiv_diagnosis.@cde.4618491
tcga_bcr.patient.follow_ups.follow_up.days_to_last_followup.@cde.3008273
tcga_bcr.patient.follow_ups.follow_up.days_to_last_known_alive.@cde.
tcga_bcr.patient.follow_ups.follow_up.days_to_last_known_alive.@cde.3131740
tcga_bcr.patient.follow_ups.follow_up.days_to_new_tumor_event_after_initial_treatment.@cde.3392464
tcga_bcr.patient.follow_ups.follow_up.days_to_performance_status_assessment.@cde.3479270
tcga_bcr.patient.follow_ups.follow_up.days_to_second_biochemical_recurrence.@cde.3414617
tcga_bcr.patient.follow_ups.follow_up.days_to_third_biochemical_recurrence.@cde.3414621
tcga_bcr.patient.follow_ups.follow_up.death_cause_text.@cde.2004150
tcga_bcr.patient.follow_ups.follow_up.diabetes.@cde.2716085
tcga_bcr.patient.follow_ups.follow_up.disease_after_curative_tx.@cde.3624727
tcga_bcr.patient.follow_ups.follow_up.dose_frequency_text.@cde.2179580
tcga_bcr.patient.follow_ups.follow_up.eastern_cancer_oncology_group.@cde.88
tcga_bcr.patient.follow_ups.follow_up.er_detection_method_text.@cde.69
tcga_bcr.patient.follow_ups.follow_up.er_level_cell_percentage_category.@cde.3128341
tcga_bcr.patient.follow_ups.follow_up.fluorescence_in_situ_hybridization_diagnostic_procedure_chromosome_17_signal_result_range.@cde.3104295
tcga_bcr.patient.follow_ups.follow_up.followup_case_report_form_submission_reason.@cde.3233305
tcga_bcr.patient.follow_ups.follow_up.followup_treatment_success.@cde.3104050
tcga_bcr.patient.follow_ups.follow_up.her2_and_centromere_17_positive_finding_other_measurement_scale_text.@cde.3087923
tcga_bcr.patient.follow_ups.follow_up.her2_erbb_method_calculation_method_text.@cde.3087487
tcga_bcr.patient.follow_ups.follow_up.her2_erbb_pos_finding_cell_percent_category.@cde.3086980
tcga_bcr.patient.follow_ups.follow_up.her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text.@cde.3087929
tcga_bcr.patient.follow_ups.follow_up.her2_immunohistochemistry_level_result.@cde.2178402
tcga_bcr.patient.follow_ups.follow_up.her2_neu_and_centromere_17_copy_number_analysis_input_total_number_count.@cde.3087902
tcga_bcr.patient.follow_ups.follow_up.her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count.@cde.3132899
tcga_bcr.patient.follow_ups.follow_up.her2_neu_breast_carcinoma_copy_analysis_input_total_number.@cde.3133738
tcga_bcr.patient.follow_ups.follow_up.her2_neu_chromosone_17_signal_ratio_value.@cde.2497552
tcga_bcr.patient.follow_ups.follow_up.her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number.@cde.3133734
tcga_bcr.patient.follow_ups.follow_up.hiv_status.@cde.2180464
tcga_bcr.patient.follow_ups.follow_up.horm_ther.@cde.3012813
tcga_bcr.patient.follow_ups.follow_up.hypertension.@cde.2183378
tcga_bcr.patient.follow_ups.follow_up.i_131_first_administered_dose.@cde.3232898
tcga_bcr.patient.follow_ups.follow_up.i_131_subsequent_administered_dose.@cde.3232904
tcga_bcr.patient.follow_ups.follow_up.i_131_total_administered_dose.@cde.3232906
tcga_bcr.patient.follow_ups.follow_up.i_131_total_administered_preparation_technique.@cde.3232952
tcga_bcr.patient.follow_ups.follow_up.immunohistochemistry_positive_cell_score.@cde.2230166
tcga_bcr.patient.follow_ups.follow_up.karnofsky_performance_score.@cde.2003853
tcga_bcr.patient.follow_ups.follow_up.lab_proc_her2_neu_immunohistochemistry_receptor_status.@cde.2957563
tcga_bcr.patient.follow_ups.follow_up.lab_procedure_her2_neu_in_situ_hybrid_outcome_type.@cde.2854089
tcga_bcr.patient.follow_ups.follow_up.lost_follow_up.@cde.61333
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result.@cde.3132444
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_estrogen_receptor_detection_method_text.@cde.3131881
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category.@cde.3131869
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_estrogen_receptor_status.@cde.3131865
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range.@cde.3132887
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text.@cde.3132452
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category.@cde.3132322
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text.@cde.3132910
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value.@cde.3132903
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score.@cde.3131873
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type.@cde.3203082
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score.@cde.3131988
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type.@cde.3203085
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status.@cde.3131997
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type.@cde.3132455
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text.@cde.3132448
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text.@cde.3132907
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text.@cde.3131992
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_progesterone_receptor_detection_method_text.@cde.3131993
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category.@cde.3131891
tcga_bcr.patient.follow_ups.follow_up.metastatic_breast_carcinoma_progesterone_receptor_status.@cde.3131884
tcga_bcr.patient.follow_ups.follow_up.method_of_curative_tx.@cde.3601546
tcga_bcr.patient.follow_ups.follow_up.mitotane_therapy_adjuvant_setting.@cde.3646377
tcga_bcr.patient.follow_ups.follow_up.molecular_test_result_list.molecular_test_result.@cde.3953322
tcga_bcr.patient.follow_ups.follow_up.month_of_form_completion.@cde.2975718
tcga_bcr.patient.follow_ups.follow_up.nadir_cd4_counts.@cde.2684395
tcga_bcr.patient.follow_ups.follow_up.new_neoplasm_event_occurrence_anatomic_site.@cde.3108271
tcga_bcr.patient.follow_ups.follow_up.new_neoplasm_event_post_initial_therapy_diagnosis_method_text.@cde.3151116
tcga_bcr.patient.follow_ups.follow_up.new_neoplasm_event_post_initial_therapy_diagnosis_method_type.@cde.3151113
tcga_bcr.patient.follow_ups.follow_up.new_neoplasm_event_type.@cde.3119721
tcga_bcr.patient.follow_ups.follow_up.new_neoplasm_event_types.new_neoplasm_event_type.@cde.3119721
tcga_bcr.patient.follow_ups.follow_up.new_neoplasm_occurrence_anatomic_site_text.@cde.3128033
tcga_bcr.patient.follow_ups.follow_up.new_tumor.additional_pharmaceutical_therapy.@cde.3427616
tcga_bcr.patient.follow_ups.follow_up.new_tumor.additional_radiation_therapy.@cde.3427615
tcga_bcr.patient.follow_ups.follow_up.new_tumor.additional_surgery_locoregional_procedure.@cde.3008755
tcga_bcr.patient.follow_ups.follow_up.new_tumor.days_to_additional_surgery_metastatic_procedure.@cde.3408682
tcga_bcr.patient.follow_ups.follow_up.new_tumor.days_to_new_tumor_event_after_initial_treatment.@cde.3392464
tcga_bcr.patient.follow_ups.follow_up.new_tumor.histologic_disease_progression_present_indicator.@cde.3181376
tcga_bcr.patient.follow_ups.follow_up.new_tumor.histologic_disease_progression_present_text.@cde.3181387
tcga_bcr.patient.follow_ups.follow_up.new_tumor.histologic_disease_progression_present_type.@cde.3181384
tcga_bcr.patient.follow_ups.follow_up.new_tumor.i_131_first_administered_dose.@cde.3232898
tcga_bcr.patient.follow_ups.follow_up.new_tumor.i_131_subsequent_administered_dose.@cde.3232904
tcga_bcr.patient.follow_ups.follow_up.new_tumor.i_131_total_administered_dose.@cde.3232906
tcga_bcr.patient.follow_ups.follow_up.new_tumor.i_131_total_administered_preparation_technique.@cde.3232952
tcga_bcr.patient.follow_ups.follow_up.new_tumor.new_neoplasm_confirmed_diagnosis_method_name.@cde.3186701
tcga_bcr.patient.follow_ups.follow_up.new_tumor.new_neoplasm_event_occurrence_anatomic_site.@cde.3108271
tcga_bcr.patient.follow_ups.follow_up.new_tumor.new_neoplasm_event_type.@cde.3119721
tcga_bcr.patient.follow_ups.follow_up.new_tumor.new_neoplasm_occurrence_anatomic_site_text.@cde.3128033
tcga_bcr.patient.follow_ups.follow_up.new_tumor.new_tumor_event_after_initial_treatment.@cde.3121376
tcga_bcr.patient.follow_ups.follow_up.new_tumor.radiation_therapy_administered_dose_text.@cde.3232933
tcga_bcr.patient.follow_ups.follow_up.new_tumor.radiation_therapy_administered_preparation_technique_text.@cde.3232960
tcga_bcr.patient.follow_ups.follow_up.new_tumor.radiosensitizing_agent_administered_indicator.@cde.3232932
tcga_bcr.patient.follow_ups.follow_up.new_tumor.therapeutic_procedure_new_neoplasm_required_additional_therapy_type.@cde.3185186
tcga_bcr.patient.follow_ups.follow_up.new_tumor.thyroid_gland_carcinoma_involvement_regional_lymph_node_type.@cde.3186207
tcga_bcr.patient.follow_ups.follow_up.new_tumor.thyroid_gland_carcinoma_regional_lymph_node_involvement_anatomic_sites_text.@cde.3185693
tcga_bcr.patient.follow_ups.follow_up.new_tumor_event_after_initial_treatment.@cde.3121376
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy.@cde.3427616
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_radiation_therapy.@cde.3427615
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_surgery_locoregional_procedure.@cde.3008755
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_surgery_metastatic_procedure.@cde.3008757
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_additional_surgery_locoregional_procedure.@cde.3408572
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_additional_surgery_metastatic_procedure.@cde.3408682
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_additional_surgery_procedure.@cde.3008335
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment.@cde.3392464
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_transplant.@cde.3008335
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_transplant.@cde.4461934
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.discontiguous_lesion_count.@cde.3162604
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.first_progression_histology_type.@cde.3282652
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.first_progression_histology_type_other.@cde.3282653
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.first_recurrence_biopsy_confirmed.@cde.2716366
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.followup_treatment_success.@cde.3104050
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count.@cde.3132899
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number.@cde.3133734
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.histologic_disease_progression_present_indicator.@cde.3181376
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.histologic_disease_progression_present_text.@cde.3181387
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.histologic_disease_progression_present_type.@cde.3181384
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.i_131_first_administered_dose.@cde.3232898
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.i_131_subsequent_administered_dose.@cde.3232904
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.i_131_total_administered_dose.@cde.3232906
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.i_131_total_administered_preparation_technique.@cde.3232952
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result.@cde.3132444
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_estrogen_receptor_detection_method_text.@cde.3131881
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category.@cde.3131869
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_estrogen_receptor_status.@cde.3131865
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range.@cde.3132887
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text.@cde.3132452
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category.@cde.3132322
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text.@cde.3132910
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value.@cde.3132903
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score.@cde.3131873
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type.@cde.3203082
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score.@cde.3131988
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type.@cde.3203085
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status.@cde.3131997
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type.@cde.3132455
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text.@cde.3132448
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text.@cde.3132907
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text.@cde.3131992
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_progesterone_receptor_detection_method_text.@cde.3131993
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category.@cde.3131891
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_progesterone_receptor_status.@cde.3131884
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_confirmed_diagnosis_method_name.@cde.3186701
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_occurrence_anatomic_site.@cde.3108271
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_post_initial_therapy_diagnosis_method_text.@cde.3151116
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_post_initial_therapy_diagnosis_method_type.@cde.3151113
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_type.@cde.3119721
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_types.new_neoplasm_event_type.@cde.3119721
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_histology_other.@cde.4500217
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_occurrence_anatomic_site_text.@cde.3128033
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.new_non_melanoma_event_histologic_type_text.@cde.3427610
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.new_primary_melanoma_anatomic_site.@cde.3430941
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.new_primary_melanoma_anatomic_site_other_text.@cde.3427598
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.new_tumor_cellular_differentiation.@cde.3194001
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.new_tumor_event_ablation_embo_tx.@cde.3173961
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.new_tumor_event_additional_surgery_procedure.@cde.3427611
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.new_tumor_event_liver_transplant.@cde.3168060
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.new_tumor_metastasis_anatomic_site.@cde.3430936
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.new_tumor_metastasis_anatomic_site_other_text.@cde.3427578
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.nte_anatomic_site_count.@cde.5675451
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.nte_tumor_sizes.nte_tumor_size.nte_pathologic_tumor_depth.@cde.3528004
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.nte_tumor_sizes.nte_tumor_size.nte_pathologic_tumor_length.@cde.3528003
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.nte_tumor_sizes.nte_tumor_size.nte_pathologic_tumor_width.@cde.3528020
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.nte_tumor_sizes.nte_tumor_size.nte_radiologic_tumor_depth.@cde.3527996
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.nte_tumor_sizes.nte_tumor_size.nte_radiologic_tumor_length.@cde.3527990
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.nte_tumor_sizes.nte_tumor_size.nte_radiologic_tumor_width.@cde.3527997
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.pathologic_tumor_burden.@cde.3162641
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.pet_scan_results.@cde.2603749
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text.@cde.3131877
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.progression_determined_by.@cde.2786205
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.progression_determined_by_list.progression_determined_by.@cde.2786205
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.progression_determined_by_notes.@cde.2786210
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.radiation_therapy_administered_dose_text.@cde.3232933
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.radiation_therapy_administered_preparation_technique_text.@cde.3232960
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.radiologic_tumor_burden.@cde.3162636
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.radiosensitizing_agent_administered_indicator.@cde.3232932
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.recurrence_second_surgery_neoplasm_surgical_procedure_name.@cde.3125097
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.recurrence_second_surgery_neoplasm_surgical_procedure_name_other.@cde.3125102
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.residual_disease_new_tumor_event.@cde.3104061
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.residual_disease_post_new_tumor_event_margin_status.@cde.3008753
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.residual_tumor.@cde.2608702
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.site_of_additional_surgery_new_tumor_event_mets.@cde.1611
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.therapeutic_procedure_new_neoplasm_required_additional_therapy_type.@cde.3185186
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.thyroid_gland_carcinoma_involvement_regional_lymph_node_type.@cde.3186207
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.thyroid_gland_carcinoma_regional_lymph_node_involvement_anatomic_sites_text.@cde.3185693
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event.tumor_multifocal.@cde.64356
tcga_bcr.patient.follow_ups.follow_up.new_tumor_events.new_tumor_event_after_initial_treatment.@cde.3121376
tcga_bcr.patient.follow_ups.follow_up.other_chemotherapy_agent_administration_specify.@cde.2426129
tcga_bcr.patient.follow_ups.follow_up.patient_death_reason.@cde.2554674
tcga_bcr.patient.follow_ups.follow_up.performance_status_scale_timing.@cde.2792763
tcga_bcr.patient.follow_ups.follow_up.person_neoplasm_cancer_status.@cde.2759550
tcga_bcr.patient.follow_ups.follow_up.pgr_detection_method_text.@cde.785
tcga_bcr.patient.follow_ups.follow_up.pos_finding_her2_erbb2_other_measurement_scale_text.@cde.3087479
tcga_bcr.patient.follow_ups.follow_up.pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text.@cde.3131877
tcga_bcr.patient.follow_ups.follow_up.pos_finding_progesterone_receptor_other_measurement_scale_text.@cde.3086857
tcga_bcr.patient.follow_ups.follow_up.positive_finding_estrogen_receptor_other_measurement_scale_text.@cde.3086851
tcga_bcr.patient.follow_ups.follow_up.post_op_ablation_embolization_tx.@cde.3172120
tcga_bcr.patient.follow_ups.follow_up.post_orchi_lymph_node_dissection.@cde.3953323
tcga_bcr.patient.follow_ups.follow_up.post_surgical_procedure_assessment_thyroid_gland_carcinoma_status.@cde.3186684
tcga_bcr.patient.follow_ups.follow_up.postoperative_rx_tx.@cde.3397567
tcga_bcr.patient.follow_ups.follow_up.pregnancies.@cde.3012512
tcga_bcr.patient.follow_ups.follow_up.primary_therapy_outcome_success.@cde.2786727
tcga_bcr.patient.follow_ups.follow_up.primary_therapy_outcome_success_at_followup.@cde.3104050
tcga_bcr.patient.follow_ups.follow_up.prior_tamoxifen_administered_usage_category.@cde.3104234
tcga_bcr.patient.follow_ups.follow_up.progesterone_receptor_level_cell_percent_category.@cde.3128342
tcga_bcr.patient.follow_ups.follow_up.progression_determined_by_list.progression_determined_by.@cde.2786205
tcga_bcr.patient.follow_ups.follow_up.radiation_supplemental.chemotherapy_negation_radiation_therapy_concurrent_administered_text.@cde.3151824
tcga_bcr.patient.follow_ups.follow_up.radiation_supplemental.chemotherapy_negation_radiation_therapy_concurrent_not_administered_reason.@cde.3151120
tcga_bcr.patient.follow_ups.follow_up.radiation_supplemental.concurrent_chemotherapy_indicator.@cde.2539220
tcga_bcr.patient.follow_ups.follow_up.radiation_supplemental.days_to_radiation_therapy_end.@cde.3008333
tcga_bcr.patient.follow_ups.follow_up.radiation_supplemental.days_to_radiation_therapy_start.@cde.3008313
tcga_bcr.patient.follow_ups.follow_up.radiation_supplemental.external_beam_radiation_therapy_administered_paraaortic_region_lymph_node_dose.@cde.3151106
tcga_bcr.patient.follow_ups.follow_up.radiation_supplemental.external_beam_radiation_therapy_administered_status.@cde.3151107
tcga_bcr.patient.follow_ups.follow_up.radiation_supplemental.rt_pelvis_administered_total_dose.@cde.3006
tcga_bcr.patient.follow_ups.follow_up.radiation_therapy.@cde.2005312
tcga_bcr.patient.follow_ups.follow_up.radiation_therapy_administered_dose_text.@cde.3232933
tcga_bcr.patient.follow_ups.follow_up.radiation_therapy_administered_preparation_technique_text.@cde.3232960
tcga_bcr.patient.follow_ups.follow_up.radiation_therapy_not_administered_reason.@cde.2733266
tcga_bcr.patient.follow_ups.follow_up.radiation_therapy_not_administered_specify.@cde.2733267
tcga_bcr.patient.follow_ups.follow_up.radiation_type_notes.@cde.2195477
tcga_bcr.patient.follow_ups.follow_up.radiosensitizing_agent_administered_indicator.@cde.3232932
tcga_bcr.patient.follow_ups.follow_up.recurrence_second_surgery_neoplasm_surgical_procedure_name.@cde.3125097
tcga_bcr.patient.follow_ups.follow_up.recurrence_second_surgery_neoplasm_surgical_procedure_name_other.@cde.3125102
tcga_bcr.patient.follow_ups.follow_up.residual_disease_post_new_tumor_event_margin_status.@cde.3008753
tcga_bcr.patient.follow_ups.follow_up.rt_administered_type.@cde.61468
tcga_bcr.patient.follow_ups.follow_up.smokeless_tobacco_use_age_at_quit.@cde.3624723
tcga_bcr.patient.follow_ups.follow_up.smokeless_tobacco_use_age_at_start.@cde.3624722
tcga_bcr.patient.follow_ups.follow_up.smokeless_tobacco_use_at_diag.@cde.3624719
tcga_bcr.patient.follow_ups.follow_up.smokeless_tobacco_use_per_day.@cde.3624721
tcga_bcr.patient.follow_ups.follow_up.smokeless_tobacco_use_regularly.@cde.3624720
tcga_bcr.patient.follow_ups.follow_up.source_of_patient_death_reason.@cde.2390921
tcga_bcr.patient.follow_ups.follow_up.subsequent_primary_melanoma_during_followup.@cde.3430950
tcga_bcr.patient.follow_ups.follow_up.therapeutic_mitotane_levels_achieved.@cde.3646378
tcga_bcr.patient.follow_ups.follow_up.treatment.concurrent_rx_tx_info.chemotherapy_negation_radiation_therapy_concurrent_administered_text.@cde.3151824
tcga_bcr.patient.follow_ups.follow_up.treatment.concurrent_rx_tx_info.chemotherapy_negation_radiation_therapy_concurrent_not_administered_reason.@cde.3151120
tcga_bcr.patient.follow_ups.follow_up.treatment.concurrent_rx_tx_info.concurrent_chemotherapy_indicator.@cde.2539220
tcga_bcr.patient.follow_ups.follow_up.treatment.concurrent_rx_tx_info.concurrent_rx_tx.agent_total_dose_count.@cde.2180805
tcga_bcr.patient.follow_ups.follow_up.treatment.concurrent_rx_tx_info.concurrent_rx_tx.chemotherapy_regimen_type.@cde.2007212
tcga_bcr.patient.follow_ups.follow_up.treatment.concurrent_rx_tx_info.concurrent_rx_tx.concurrent_chemotherapy_dose.@cde.3166172
tcga_bcr.patient.follow_ups.follow_up.treatment.concurrent_rx_tx_info.concurrent_rx_tx.dose_frequency_text.@cde.2179580
tcga_bcr.patient.follow_ups.follow_up.treatment.concurrent_rx_tx_info.concurrent_rx_tx.other_chemotherapy_agent_administration_specify.@cde.2426129
tcga_bcr.patient.follow_ups.follow_up.treatment.postoperative_rx_tx.@cde.3397567
tcga_bcr.patient.follow_ups.follow_up.treatment.radiation_therapy.@cde.2005312
tcga_bcr.patient.follow_ups.follow_up.treatment.radiation_therapy_info.brachytherapy_first_reference_point_administered_total_dose.@cde.3151100
tcga_bcr.patient.follow_ups.follow_up.treatment.radiation_therapy_info.brachytherapy_method_other_specify_text.@cde.3150976
tcga_bcr.patient.follow_ups.follow_up.treatment.radiation_therapy_info.brachytherapy_method_type.@cde.2966127
tcga_bcr.patient.follow_ups.follow_up.treatment.radiation_therapy_info.external_beam_radiation_therapy_administered_paraaortic_region_lymph_node_dose.@cde.3151106
tcga_bcr.patient.follow_ups.follow_up.treatment.radiation_therapy_info.radiation_therapy_not_administered_reason.@cde.2733266
tcga_bcr.patient.follow_ups.follow_up.treatment.radiation_therapy_info.radiation_therapy_not_administered_specify.@cde.2733267
tcga_bcr.patient.follow_ups.follow_up.treatment.radiation_therapy_info.radiation_type_notes.@cde.2195477
tcga_bcr.patient.follow_ups.follow_up.treatment.radiation_therapy_info.rt_administered_type.@cde.61468
tcga_bcr.patient.follow_ups.follow_up.treatment.radiation_therapy_info.rt_pelvis_administered_total_dose.@cde.3006
tcga_bcr.patient.follow_ups.follow_up.tumor_progression_post_ht.@cde.3158820
tcga_bcr.patient.follow_ups.follow_up.type_ofprogression_of_disease_ht.@cde.3354944
tcga_bcr.patient.follow_ups.follow_up.vital_status.@cde.5
tcga_bcr.patient.follow_ups.follow_up.year_of_form_completion.@cde.2975720
tcga_bcr.patient.food_allergy_history.@cde.3121278
tcga_bcr.patient.food_allergy_types.@cde.3121280
tcga_bcr.patient.frequency_of_alcohol_consumption.@cde.3114013
tcga_bcr.patient.gender.@cde.2200604
tcga_bcr.patient.genotype_analysis_performed_indicator.@cde.3179001
tcga_bcr.patient.genotyping_results_gene_mutation_not_reported_reasons.genotyping_results_gene_mutation_not_reported_reason.@cde.3179383
tcga_bcr.patient.germline_testing_performed.@cde.3121565
tcga_bcr.patient.goblet_cells_present.@cde.3440216
tcga_bcr.patient.h_pylori_infection.@cde.3440211
tcga_bcr.patient.hay_fever_history.@cde.3133930
tcga_bcr.patient.headache_history.@cde.3121345
tcga_bcr.patient.height.@cde.649
tcga_bcr.patient.hemoglobin_result.@cde.3113466
tcga_bcr.patient.her2_and_centromere_17_positive_finding_other_measurement_scale_text.@cde.3087923
tcga_bcr.patient.her2_erbb_method_calculation_method_text.@cde.3087487
tcga_bcr.patient.her2_erbb_pos_finding_cell_percent_category.@cde.3086980
tcga_bcr.patient.her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text.@cde.3087929
tcga_bcr.patient.her2_immunohistochemistry_level_result.@cde.2178402
tcga_bcr.patient.her2_neu_and_centromere_17_copy_number_analysis_input_total_number_count.@cde.3087902
tcga_bcr.patient.her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count.@cde.3132899
tcga_bcr.patient.her2_neu_breast_carcinoma_copy_analysis_input_total_number.@cde.3133738
tcga_bcr.patient.her2_neu_chromosone_17_signal_ratio_value.@cde.2497552
tcga_bcr.patient.her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number.@cde.3133734
tcga_bcr.patient.histologic_grading_tier_category.@cde.3385981
tcga_bcr.patient.histological_type.@cde.3081934
tcga_bcr.patient.histological_type_other.@cde.3124492
tcga_bcr.patient.history_asbestos_exposure.@cde.1253
tcga_bcr.patient.history_fertility.@cde.3896771
tcga_bcr.patient.history_hepato_carcinoma_risk_factors.hist_hepato_carc_fact.@cde.3171846
tcga_bcr.patient.history_hepato_carcinoma_risk_factors.hist_hepato_carcinoma_risk.@cde.3171859
tcga_bcr.patient.history_hypospadias.@cde.3896751
tcga_bcr.patient.history_ionizing_rt_to_head.@cde.3120926
tcga_bcr.patient.history_non_muscle_invasive_blca.complete_response_observed.@cde.3436262
tcga_bcr.patient.history_non_muscle_invasive_blca.hist_of_non_mibc.@cde.3436253
tcga_bcr.patient.history_non_muscle_invasive_blca.induction_course_complete.@cde.3436265
tcga_bcr.patient.history_non_muscle_invasive_blca.maint_therapy_course_complete.@cde.3436266
tcga_bcr.patient.history_non_muscle_invasive_blca.mibc_90day_post_resection_bcg.@cde.3436260
tcga_bcr.patient.history_non_muscle_invasive_blca.non_mibc_tx.@cde.3436357
tcga_bcr.patient.history_non_muscle_invasive_blca.resp_maint_from_bcg_admin_month_dur.@cde.3436267
tcga_bcr.patient.history_of_chronic_pancreatitis.@cde.3457760
tcga_bcr.patient.history_of_colon_polyps.@cde.3107197
tcga_bcr.patient.history_of_diabetes.@cde.3197322
tcga_bcr.patient.history_of_disease.cd4_counts_at_diagnosis.@cde.2922654
tcga_bcr.patient.history_of_disease.cdc_hiv_risk_group.@cde.2542215
tcga_bcr.patient.history_of_disease.days_to_hiv_diagnosis.@cde.4618491
tcga_bcr.patient.history_of_disease.hbv_test.@cde.2180456
tcga_bcr.patient.history_of_disease.hcv_test.@cde.2695021
tcga_bcr.patient.history_of_disease.history_immunological_disease_other.@cde.3233629
tcga_bcr.patient.history_of_disease.history_immunological_diseases.history_immunological_disease.@cde.3233628
tcga_bcr.patient.history_of_disease.history_immunosuppresive_rx_types.history_immunosuppresive_rx.@cde.3233638
tcga_bcr.patient.history_of_disease.history_immunosuppressive_rx_other.@cde.2873928
tcga_bcr.patient.history_of_disease.history_of_other_malignancy.@cde.2718428
tcga_bcr.patient.history_of_disease.history_relevant_infectious_diseases.history_relevant_infectious_dx.@cde.3233642
tcga_bcr.patient.history_of_disease.history_relevant_infectious_dx.@cde.3233642
tcga_bcr.patient.history_of_disease.history_relevant_infectious_dx_other.@cde.3233643
tcga_bcr.patient.history_of_disease.hiv_rna_load_at_diagnosis.@cde.2922674
tcga_bcr.patient.history_of_disease.hiv_status.@cde.2180464
tcga_bcr.patient.history_of_disease.hpv_test.@cde.2230033
tcga_bcr.patient.history_of_disease.kshv_hhv8_test.@cde.3335773
tcga_bcr.patient.history_of_disease.nadir_cd4_counts.@cde.2684395
tcga_bcr.patient.history_of_disease.on_haart_therapy_at_cancer_diagnosis.@cde.2922679
tcga_bcr.patient.history_of_disease.on_haart_therapy_prior_to_cancer_diagnosis.@cde.3335156
tcga_bcr.patient.history_of_disease.other_dx.@cde.3382736
tcga_bcr.patient.history_of_disease.prior_aids_conditions.@cde.2679581
tcga_bcr.patient.history_of_esophageal_cancer.@cde.3440217
tcga_bcr.patient.history_of_neoadjuvant_treatment.@cde.3382737
tcga_bcr.patient.history_of_undescended_testis.@cde.3896542
tcga_bcr.patient.history_pheo_or_para_anatomic_site.@cde.3693062
tcga_bcr.patient.history_pheo_or_para_include_benign.@cde.3641293
tcga_bcr.patient.history_prior_surgery_type_other.@cde.3121814
tcga_bcr.patient.horm_ther.@cde.3012813
tcga_bcr.patient.hpv_status_by_ish_testing.@cde.3108261
tcga_bcr.patient.hpv_status_by_p16_testing.@cde.3108263
tcga_bcr.patient.human_papillomavirus_laboratory_procedure_performed_name.@cde.3151457
tcga_bcr.patient.human_papillomavirus_laboratory_procedure_performed_text.@cde.3151460
tcga_bcr.patient.human_papillomavirus_other_type_text.@cde.3166168
tcga_bcr.patient.human_papillomavirus_types.human_papillomavirus_type.@cde.2922649
tcga_bcr.patient.hydroxyurea_administration_prior_registration_clinical_study_indicator.@cde.3121638
tcga_bcr.patient.hydroxyurea_agent_administered_day_count.@cde.2724416
tcga_bcr.patient.hypertension.@cde.2183378
tcga_bcr.patient.hysterectomy_performed_text.@cde.3151506
tcga_bcr.patient.hysterectomy_performed_type.@cde.2647164
tcga_bcr.patient.i_131_first_administered_dose.@cde.3232898
tcga_bcr.patient.i_131_subsequent_administered_dose.@cde.3232904
tcga_bcr.patient.i_131_total_administered_dose.@cde.3232906
tcga_bcr.patient.i_131_total_administered_preparation_technique.@cde.3232952
tcga_bcr.patient.icd_10.@cde.3226287
tcga_bcr.patient.icd_o_3_histology.@cde.3226275
tcga_bcr.patient.icd_o_3_site.@cde.3226281
tcga_bcr.patient.immunohistochemistry_positive_cell_score.@cde.2230166
tcga_bcr.patient.immunophenotype_cytochemistry_testing_results.immunophenotype_cytochemistry_testing_result_values.immunophenotype_cytochemistry_percent_positive.@cde.3121491
tcga_bcr.patient.immunophenotype_cytochemistry_testing_results.immunophenotype_cytochemistry_testing_result_values.immunophenotype_cytochemistry_testing_result.@cde.3121483
tcga_bcr.patient.informed_consent_verified.@cde.3288361
tcga_bcr.patient.inherited_genetic_syndrome_found.@cde.3133971
tcga_bcr.patient.inherited_genetic_syndrome_result.@cde.3133974
tcga_bcr.patient.init_pathology_dx_method_other.@cde.2757948
tcga_bcr.patient.initial_diagnosis_by.@cde.3440213
tcga_bcr.patient.initial_pathologic_diagnosis_method.@cde.2757941
tcga_bcr.patient.inter_norm_ratio_lower_limit.@cde.2799755
tcga_bcr.patient.interferon_90_day_prior_excision_admin_indicator.@cde.3162803
tcga_bcr.patient.intern_norm_ratio_upper_limit.@cde.3171875
tcga_bcr.patient.jewish_origin.@cde.2200537
tcga_bcr.patient.karnofsky_performance_score.@cde.2003853
tcga_bcr.patient.keratinizing_squamous_cell_carcinoma_present_indicator.@cde.3151599
tcga_bcr.patient.kras_gene_analysis_performed.@cde.3123147
tcga_bcr.patient.kras_mutation_codon.@cde.3124509
tcga_bcr.patient.kras_mutation_found.@cde.2932340
tcga_bcr.patient.kras_mutation_result.@cde.3147614
tcga_bcr.patient.lab_proc_her2_neu_immunohistochemistry_receptor_status.@cde.2957563
tcga_bcr.patient.lab_procedure_abnormal_lymphocyte_result_percent_value.@cde.3144381
tcga_bcr.patient.lab_procedure_blast_cell_outcome_percentage_value.@cde.58282
tcga_bcr.patient.lab_procedure_bone_marrow_band_cell_result_percent_value.@cde.3131180
tcga_bcr.patient.lab_procedure_bone_marrow_basophil_result_percent_value.@cde.64507
tcga_bcr.patient.lab_procedure_bone_marrow_blast_cell_outcome_percent_value.@cde.58262
tcga_bcr.patient.lab_procedure_bone_marrow_cellularity_outcome_percent_value.@cde.58264
tcga_bcr.patient.lab_procedure_bone_marrow_diff_not_reported_reason.@cde.3131184
tcga_bcr.patient.lab_procedure_bone_marrow_lab_eosinophil_result_percent_value.@cde.58266
tcga_bcr.patient.lab_procedure_bone_marrow_lymphocyte_outcome_percent_value.@cde.58270
tcga_bcr.patient.lab_procedure_bone_marrow_metamyelocyte_result_value.@cde.2669787
tcga_bcr.patient.lab_procedure_bone_marrow_myelocyte_result_percent_value.@cde.2669788
tcga_bcr.patient.lab_procedure_bone_marrow_neutrophil_result_percent_value.@cde.2669786
tcga_bcr.patient.lab_procedure_bone_marrow_prolymphocyte_result_percent_value.@cde.2669789
tcga_bcr.patient.lab_procedure_bone_marrow_promonocyte_count_result_percent_value.@cde.3131695
tcga_bcr.patient.lab_procedure_bone_marrow_promyelocyte_result_percent_value.@cde.58271
tcga_bcr.patient.lab_procedure_hematocrit_outcome_percent_value.@cde.2180444
tcga_bcr.patient.lab_procedure_hemoglobin_result_specified_value.@cde.2190
tcga_bcr.patient.lab_procedure_her2_neu_in_situ_hybrid_outcome_type.@cde.2854089
tcga_bcr.patient.lab_procedure_leukocyte_result_unspecified_value.@cde.2006107
tcga_bcr.patient.lab_procedure_monocyte_result_percent_value.@cde.58301
tcga_bcr.patient.laboratory_procedure_tumor_marker_squamous_cell_carcinoma_antigen_result_value.@cde.3151234
tcga_bcr.patient.lactate_dehydrogenase_result.@cde.3113468
tcga_bcr.patient.laterality.@cde.827
tcga_bcr.patient.ldh1_mutation_found.@cde.3133967
tcga_bcr.patient.ldh1_mutation_test_method.@cde.3133963
tcga_bcr.patient.ldh1_mutation_tested.@cde.3133962
tcga_bcr.patient.leukemia_french_american_british_morphology_code.@cde.3124352
tcga_bcr.patient.leukemia_specimen_cell_source_type.@cde.64583
tcga_bcr.patient.level_of_non_descent.@cde.3896671
tcga_bcr.patient.location_in_lung_parenchyma.@cde.3139453
tcga_bcr.patient.loss_expression_of_mismatch_repair_proteins_by_ihc.@cde.3123153
tcga_bcr.patient.loss_expression_of_mismatch_repair_proteins_by_ihc_results.loss_expression_of_mismatch_repair_proteins_by_ihc_result.@cde.3105496
tcga_bcr.patient.lost_follow_up.@cde.61333
tcga_bcr.patient.lymph_node_examined_count.@cde.3
tcga_bcr.patient.lymph_node_location_positive_pathology_names.lymph_node_location_positive_pathology_name.@cde.3151519
tcga_bcr.patient.lymph_node_location_positive_pathology_text.@cde.3151522
tcga_bcr.patient.lymph_node_preoperative_assessment_diagnostic_imaging_types.lymph_node_preoperative_assessment_diagnostic_imaging_type.@cde.3178310
tcga_bcr.patient.lymph_node_preoperative_scan_indicator.@cde.3178301
tcga_bcr.patient.lymphatic_invasion.@cde.64171
tcga_bcr.patient.lymphnode_dissection_method_left.@cde.3113989
tcga_bcr.patient.lymphnode_dissection_method_right.@cde.3124514
tcga_bcr.patient.lymphnode_neck_dissection.@cde.2238421
tcga_bcr.patient.lymphnodes_examined.@cde.2200396
tcga_bcr.patient.lymphovascular_invasion_indicator.@cde.64727
tcga_bcr.patient.lymphovascular_invasion_present.@cde.64727
tcga_bcr.patient.malignant_neoplasm_mitotic_count_rate.@cde.3119292
tcga_bcr.patient.margin_status.@cde.3114007
tcga_bcr.patient.maximum_tumor_dimension.@cde.64215
tcga_bcr.patient.melanoma_clark_level_value.@cde.2593051
tcga_bcr.patient.melanoma_origin_skin_anatomic_site.@cde.3108474
tcga_bcr.patient.melanoma_ulceration_indicator.@cde.3108478
tcga_bcr.patient.menopause_status.@cde.2957270
tcga_bcr.patient.mental_status_changes.@cde.3121352
tcga_bcr.patient.metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result.@cde.3132444
tcga_bcr.patient.metastatic_breast_carcinoma_estrogen_receptor_detection_method_text.@cde.3131881
tcga_bcr.patient.metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category.@cde.3131869
tcga_bcr.patient.metastatic_breast_carcinoma_estrogen_receptor_status.@cde.3131865
tcga_bcr.patient.metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range.@cde.3132887
tcga_bcr.patient.metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text.@cde.3132452
tcga_bcr.patient.metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category.@cde.3132322
tcga_bcr.patient.metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text.@cde.3132910
tcga_bcr.patient.metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value.@cde.3132903
tcga_bcr.patient.metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score.@cde.3131873
tcga_bcr.patient.metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score.@cde.3131988
tcga_bcr.patient.metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status.@cde.3131997
tcga_bcr.patient.metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type.@cde.3132455
tcga_bcr.patient.metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text.@cde.3132448
tcga_bcr.patient.metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text.@cde.3132907
tcga_bcr.patient.metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text.@cde.3131992
tcga_bcr.patient.metastatic_breast_carcinoma_progesterone_receptor_detection_method_text.@cde.3131993
tcga_bcr.patient.metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category.@cde.3131891
tcga_bcr.patient.metastatic_breast_carcinoma_progesterone_receptor_status.@cde.3131884
tcga_bcr.patient.metastatic_neoplasm_confirmed_diagnosis_method_names.metastatic_neoplasm_confirmed_diagnosis_method_name.@cde.3178364
tcga_bcr.patient.metastatic_neoplasm_confirmed_diagnosis_method_text.@cde.3178376
tcga_bcr.patient.metastatic_site.@cde.62835
tcga_bcr.patient.metastatic_site_list.metastatic_site.@cde.62835
tcga_bcr.patient.microsatellite_instability.@cde.3123142
tcga_bcr.patient.mitotane_therapy.@cde.3646372
tcga_bcr.patient.mitotane_therapy_adjuvant_setting.@cde.3646377
tcga_bcr.patient.mitotane_therapy_for_macroscopic_residual_disease.@cde.3646385
tcga_bcr.patient.mold_or_dust_allergy_history.@cde.3133934
tcga_bcr.patient.molecular_analysis_abnormal_result_indicator.@cde.3121579
tcga_bcr.patient.molecular_analysis_abnormality_testing_results.molecular_analysis_abnormality_testing_result_values.molecular_analysis_abnormality_testing_percentage_value.@cde.3151753
tcga_bcr.patient.molecular_analysis_abnormality_testing_results.molecular_analysis_abnormality_testing_result_values.molecular_analysis_abnormality_testing_result.@cde.3121628
tcga_bcr.patient.month_of_form_completion.@cde.2975718
tcga_bcr.patient.motor_movement_changes.@cde.3120991
tcga_bcr.patient.neoplasm_dimension.neoplasm_depth.@cde.2764966
tcga_bcr.patient.neoplasm_dimension.neoplasm_length.@cde.2764966
tcga_bcr.patient.neoplasm_dimension.neoplasm_width.@cde.2764966
tcga_bcr.patient.neoplasm_histologic_grade.@cde.2785839
tcga_bcr.patient.new_tumor_events.new_tumor_dx_prior_submitted_specimen_dx.@cde.3427563
tcga_bcr.patient.new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy.@cde.3427616
tcga_bcr.patient.new_tumor_events.new_tumor_event.additional_radiation_therapy.@cde.3427615
tcga_bcr.patient.new_tumor_events.new_tumor_event.additional_surgery_locoregional_procedure.@cde.3008755
tcga_bcr.patient.new_tumor_events.new_tumor_event.additional_surgery_metastatic_procedure.@cde.3008757
tcga_bcr.patient.new_tumor_events.new_tumor_event.days_to_additional_surgery_locoregional_procedure.@cde.3408572
tcga_bcr.patient.new_tumor_events.new_tumor_event.days_to_additional_surgery_metastatic_procedure.@cde.3408682
tcga_bcr.patient.new_tumor_events.new_tumor_event.days_to_new_tumor_event_additional_surgery_procedure.@cde.3008335
tcga_bcr.patient.new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment.@cde.3392464
tcga_bcr.patient.new_tumor_events.new_tumor_event.days_to_new_tumor_event_transplant.@cde.3008335
tcga_bcr.patient.new_tumor_events.new_tumor_event.days_to_new_tumor_event_transplant.@cde.4461934
tcga_bcr.patient.new_tumor_events.new_tumor_event.discontiguous_lesion_count.@cde.3162604
tcga_bcr.patient.new_tumor_events.new_tumor_event.first_progression_histology_type.@cde.3282652
tcga_bcr.patient.new_tumor_events.new_tumor_event.first_progression_histology_type_other.@cde.3282653
tcga_bcr.patient.new_tumor_events.new_tumor_event.first_recurrence_biopsy_confirmed.@cde.2716366
tcga_bcr.patient.new_tumor_events.new_tumor_event.followup_treatment_success.@cde.3104050
tcga_bcr.patient.new_tumor_events.new_tumor_event.her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count.@cde.3132899
tcga_bcr.patient.new_tumor_events.new_tumor_event.her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number.@cde.3133734
tcga_bcr.patient.new_tumor_events.new_tumor_event.histologic_disease_progression_present_indicator.@cde.3181376
tcga_bcr.patient.new_tumor_events.new_tumor_event.histologic_disease_progression_present_text.@cde.3181387
tcga_bcr.patient.new_tumor_events.new_tumor_event.histologic_disease_progression_present_type.@cde.3181384
tcga_bcr.patient.new_tumor_events.new_tumor_event.i_131_first_administered_dose.@cde.3232898
tcga_bcr.patient.new_tumor_events.new_tumor_event.i_131_subsequent_administered_dose.@cde.3232904
tcga_bcr.patient.new_tumor_events.new_tumor_event.i_131_total_administered_dose.@cde.3232906
tcga_bcr.patient.new_tumor_events.new_tumor_event.i_131_total_administered_preparation_technique.@cde.3232952
tcga_bcr.patient.new_tumor_events.new_tumor_event.locoregional_procedure.additional_surgery_locoregional_procedure.@cde.3008755
tcga_bcr.patient.new_tumor_events.new_tumor_event.locoregional_procedure.days_to_additional_surgery_locoregional_procedure.@cde.3408572
tcga_bcr.patient.new_tumor_events.new_tumor_event.locoregional_procedure.residual_disease_post_new_tumor_event_margin_status.@cde.3008753
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result.@cde.3132444
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_estrogen_receptor_detection_method_text.@cde.3131881
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category.@cde.3131869
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_estrogen_receptor_status.@cde.3131865
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range.@cde.3132887
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text.@cde.3132452
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category.@cde.3132322
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text.@cde.3132910
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value.@cde.3132903
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score.@cde.3131873
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type.@cde.3203082
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score.@cde.3131988
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type.@cde.3203085
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status.@cde.3131997
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type.@cde.3132455
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text.@cde.3132448
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text.@cde.3132907
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text.@cde.3131992
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_progesterone_receptor_detection_method_text.@cde.3131993
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category.@cde.3131891
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_progesterone_receptor_status.@cde.3131884
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_procedure.additional_surgery_metastatic_procedure.@cde.3008757
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_procedure.days_to_additional_surgery_metastatic_procedure.@cde.3408682
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_procedure.new_neoplasm_event_occurrence_anatomic_site.@cde.3108271
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_procedure.new_neoplasm_occurrence_anatomic_site_text.@cde.3128033
tcga_bcr.patient.new_tumor_events.new_tumor_event.metastatic_procedure.residual_disease_post_new_tumor_event_margin_status.@cde.3008753
tcga_bcr.patient.new_tumor_events.new_tumor_event.new_neoplasm_confirmed_diagnosis_method_name.@cde.3186701
tcga_bcr.patient.new_tumor_events.new_tumor_event.new_neoplasm_event_occurrence_anatomic_site.@cde.3108271
tcga_bcr.patient.new_tumor_events.new_tumor_event.new_neoplasm_event_post_initial_therapy_diagnosis_method_text.@cde.3151116
tcga_bcr.patient.new_tumor_events.new_tumor_event.new_neoplasm_event_post_initial_therapy_diagnosis_method_type.@cde.3151113
tcga_bcr.patient.new_tumor_events.new_tumor_event.new_neoplasm_event_type.@cde.3119721
tcga_bcr.patient.new_tumor_events.new_tumor_event.new_neoplasm_event_types.new_neoplasm_event_type.@cde.3119721
tcga_bcr.patient.new_tumor_events.new_tumor_event.new_neoplasm_histology_other.@cde.4500217
tcga_bcr.patient.new_tumor_events.new_tumor_event.new_neoplasm_occurrence_anatomic_site_text.@cde.3128033
tcga_bcr.patient.new_tumor_events.new_tumor_event.new_non_melanoma_event_histologic_type_text.@cde.3427610
tcga_bcr.patient.new_tumor_events.new_tumor_event.new_primary_melanoma_anatomic_site.@cde.3430941
tcga_bcr.patient.new_tumor_events.new_tumor_event.new_primary_melanoma_anatomic_site_other_text.@cde.3427598
tcga_bcr.patient.new_tumor_events.new_tumor_event.new_tumor_cellular_differentiation.@cde.3194001
tcga_bcr.patient.new_tumor_events.new_tumor_event.new_tumor_event_ablation_embo_tx.@cde.3173961
tcga_bcr.patient.new_tumor_events.new_tumor_event.new_tumor_event_additional_surgery_procedure.@cde.3427611
tcga_bcr.patient.new_tumor_events.new_tumor_event.new_tumor_event_liver_transplant.@cde.3168060
tcga_bcr.patient.new_tumor_events.new_tumor_event.new_tumor_metastasis_anatomic_site.@cde.3430936
tcga_bcr.patient.new_tumor_events.new_tumor_event.new_tumor_metastasis_anatomic_site_other_text.@cde.3427578
tcga_bcr.patient.new_tumor_events.new_tumor_event.nte_anatomic_site_count.@cde.5675451
tcga_bcr.patient.new_tumor_events.new_tumor_event.nte_tumor_sizes.nte_tumor_size.nte_pathologic_tumor_depth.@cde.3528004
tcga_bcr.patient.new_tumor_events.new_tumor_event.nte_tumor_sizes.nte_tumor_size.nte_pathologic_tumor_length.@cde.3528003
tcga_bcr.patient.new_tumor_events.new_tumor_event.nte_tumor_sizes.nte_tumor_size.nte_pathologic_tumor_width.@cde.3528020
tcga_bcr.patient.new_tumor_events.new_tumor_event.nte_tumor_sizes.nte_tumor_size.nte_radiologic_tumor_depth.@cde.3527996
tcga_bcr.patient.new_tumor_events.new_tumor_event.nte_tumor_sizes.nte_tumor_size.nte_radiologic_tumor_length.@cde.3527990
tcga_bcr.patient.new_tumor_events.new_tumor_event.nte_tumor_sizes.nte_tumor_size.nte_radiologic_tumor_width.@cde.3527997
tcga_bcr.patient.new_tumor_events.new_tumor_event.pathologic_tumor_burden.@cde.3162641
tcga_bcr.patient.new_tumor_events.new_tumor_event.pet_scan_results.@cde.2603749
tcga_bcr.patient.new_tumor_events.new_tumor_event.pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text.@cde.3131877
tcga_bcr.patient.new_tumor_events.new_tumor_event.progression_determined_by.@cde.2786205
tcga_bcr.patient.new_tumor_events.new_tumor_event.progression_determined_by_list.progression_determined_by.@cde.2786205
tcga_bcr.patient.new_tumor_events.new_tumor_event.progression_determined_by_notes.@cde.2786210
tcga_bcr.patient.new_tumor_events.new_tumor_event.radiation_therapy_administered_dose_text.@cde.3232933
tcga_bcr.patient.new_tumor_events.new_tumor_event.radiation_therapy_administered_preparation_technique_text.@cde.3232960
tcga_bcr.patient.new_tumor_events.new_tumor_event.radiologic_tumor_burden.@cde.3162636
tcga_bcr.patient.new_tumor_events.new_tumor_event.radiosensitizing_agent_administered_indicator.@cde.3232932
tcga_bcr.patient.new_tumor_events.new_tumor_event.recurrence_second_surgery_neoplasm_surgical_procedure_name.@cde.3125097
tcga_bcr.patient.new_tumor_events.new_tumor_event.recurrence_second_surgery_neoplasm_surgical_procedure_name_other.@cde.3125102
tcga_bcr.patient.new_tumor_events.new_tumor_event.residual_disease_new_tumor_event.@cde.3104061
tcga_bcr.patient.new_tumor_events.new_tumor_event.residual_disease_post_new_tumor_event_margin_status.@cde.3008753
tcga_bcr.patient.new_tumor_events.new_tumor_event.residual_tumor.@cde.2608702
tcga_bcr.patient.new_tumor_events.new_tumor_event.site_of_additional_surgery_new_tumor_event_mets.@cde.1611
tcga_bcr.patient.new_tumor_events.new_tumor_event.therapeutic_procedure_new_neoplasm_required_additional_therapy_type.@cde.3185186
tcga_bcr.patient.new_tumor_events.new_tumor_event.thyroid_gland_carcinoma_involvement_regional_lymph_node_type.@cde.3186207
tcga_bcr.patient.new_tumor_events.new_tumor_event.thyroid_gland_carcinoma_regional_lymph_node_involvement_anatomic_sites_text.@cde.3185693
tcga_bcr.patient.new_tumor_events.new_tumor_event.tumor_multifocal.@cde.64356
tcga_bcr.patient.new_tumor_events.new_tumor_event.tumor_progression_post_ht.@cde.3158820
tcga_bcr.patient.new_tumor_events.new_tumor_event.type_of_progression_after_ht.@cde.3354944
tcga_bcr.patient.new_tumor_events.new_tumor_event_after_initial_treatment.@cde.3121376
tcga_bcr.patient.non_nodal_tumor_deposits.@cde.3107051
tcga_bcr.patient.number_of_abnormal_loci.@cde.3107129
tcga_bcr.patient.number_of_first_degree_relatives_with_cancer_diagnosis.@cde.3107205
tcga_bcr.patient.number_of_loci_tested.@cde.3107127
tcga_bcr.patient.number_of_lymphnodes_examined.@cde.3
tcga_bcr.patient.number_of_lymphnodes_positive.@cde.89
tcga_bcr.patient.number_of_lymphnodes_positive_by_he.@cde.3086388
tcga_bcr.patient.number_of_lymphnodes_positive_by_ihc.@cde.3086383
tcga_bcr.patient.number_of_relatives_diagnosed.@cde.3440229
tcga_bcr.patient.number_of_relatives_with_stomach_cancer.@cde.3203277
tcga_bcr.patient.number_of_successful_pregnancies_which_resulted_in_at_least_1_live_birth.@cde.2183299
tcga_bcr.patient.number_pack_years_smoked.@cde.2955385
tcga_bcr.patient.occupation_primary_job.@cde.5714
tcga_bcr.patient.oligonucleotide_primer_pair_laboratory_procedure_performed_name.@cde.3151487
tcga_bcr.patient.oligonucleotide_primer_pair_laboratory_procedure_performed_text.@cde.3151490
tcga_bcr.patient.omfs.omf.bcr_omf_uuid.@cde.
tcga_bcr.patient.omfs.omf.day_of_form_completion.@cde.2975716
tcga_bcr.patient.omfs.omf.days_to_other_malignancy_dx.@cde.3462301
tcga_bcr.patient.omfs.omf.drug_tx.administered_drug.drug_name.@cde.2975232
tcga_bcr.patient.omfs.omf.drug_tx.days_to_drug_therapy_start.@cde.3392465
tcga_bcr.patient.omfs.omf.drug_tx.drug_tx_extent.@cde.3178365
tcga_bcr.patient.omfs.omf.drug_tx.drug_tx_indicator.@cde.3178327
tcga_bcr.patient.omfs.omf.malignancy_type.@cde.3182890
tcga_bcr.patient.omfs.omf.month_of_form_completion.@cde.2975718
tcga_bcr.patient.omfs.omf.omf_staging.clinical_stage.@cde.3225684
tcga_bcr.patient.omfs.omf.omf_staging.pathologic_categories.pathologic_M.@cde.3045439
tcga_bcr.patient.omfs.omf.omf_staging.pathologic_categories.pathologic_N.@cde.3203106
tcga_bcr.patient.omfs.omf.omf_staging.pathologic_categories.pathologic_T.@cde.3045435
tcga_bcr.patient.omfs.omf.omf_staging.pathologic_stage.@cde.3203222
tcga_bcr.patient.omfs.omf.omf_staging.system_version.@cde.2722309
tcga_bcr.patient.omfs.omf.omf_staging.system_version.@cde.3114049
tcga_bcr.patient.omfs.omf.other_malignancy_anatomic_site.@cde.4122351
tcga_bcr.patient.omfs.omf.other_malignancy_anatomic_site_text.@cde.4122371
tcga_bcr.patient.omfs.omf.other_malignancy_histological_type.@cde.4122411
tcga_bcr.patient.omfs.omf.other_malignancy_histological_type_text.@cde.4122431
tcga_bcr.patient.omfs.omf.other_malignancy_laterality.@cde.4122391
tcga_bcr.patient.omfs.omf.radiation_tx.days_to_radiation_therapy_start.@cde.3008313
tcga_bcr.patient.omfs.omf.radiation_tx.rad_tx_to_site_of_primary_tumor.@cde.2865132
tcga_bcr.patient.omfs.omf.radiation_tx.radiation_tx_extent.@cde.3178353
tcga_bcr.patient.omfs.omf.radiation_tx.radiation_tx_indicator.@cde.3178328
tcga_bcr.patient.omfs.omf.surgery.days_to_surgical_resection.@cde.3462302
tcga_bcr.patient.omfs.omf.surgery.surgery_indicator.@cde.3186538
tcga_bcr.patient.omfs.omf.surgery.surgery_type.@cde.3462300
tcga_bcr.patient.omfs.omf.year_of_form_completion.@cde.2975720
tcga_bcr.patient.other_dx.@cde.3382736
tcga_bcr.patient.other_genotyping_outcome_lab_results_text.@cde.3179278
tcga_bcr.patient.other_metastatic_site.@cde.3135371
tcga_bcr.patient.p53_gene_analysis.@cde.3124938
tcga_bcr.patient.patient_death_reason.@cde.2554674
tcga_bcr.patient.patient_history_immune_system_and_related_disorders_names.patient_history_immune_system_and_related_disorders_name.@cde.3151446
tcga_bcr.patient.patient_history_immune_system_and_related_disorders_text.@cde.3151449
tcga_bcr.patient.patient_id.@cde.
tcga_bcr.patient.patient_personal_medical_history_thyroid_gland_disorder_names.patient_personal_medical_history_thyroid_gland_disorder_name.@cde.3176743
tcga_bcr.patient.patient_personal_medical_history_thyroid_other_specify_text.@cde.3179397
tcga_bcr.patient.patient_pregnancy_spontaneous_abortion_count.@cde.2180637
tcga_bcr.patient.patient_pregnancy_therapeutic_abortion_count.@cde.2180648
tcga_bcr.patient.pct_tumor_invasion.@cde.3104403
tcga_bcr.patient.percent_tumor_sarcomatoid.@cde.2429786
tcga_bcr.patient.performance_status_scale_timing.@cde.2792763
tcga_bcr.patient.perineural_invasion_present.@cde.64181
tcga_bcr.patient.peritoneal_wash.@cde.61384
tcga_bcr.patient.person_concomitant_prostate_carcinoma_occurrence_indicator.@cde.3135387
tcga_bcr.patient.person_concomitant_prostate_carcinoma_pathologic_t_stage.@cde.3135398
tcga_bcr.patient.person_history_leukemogenic_agent_other_exposure_text.@cde.3131188
tcga_bcr.patient.person_history_nonmedical_leukemia_causing_agent_type.@cde.3121309
tcga_bcr.patient.person_lifetime_risk_radiation_exposure_indicator.@cde.2816350
tcga_bcr.patient.person_neoplasm_cancer_status.@cde.2759550
tcga_bcr.patient.person_occupation_description_text.@cde.2435398
tcga_bcr.patient.person_occupation_years_number.@cde.2435424
tcga_bcr.patient.person_primary_industry_text.@cde.3135408
tcga_bcr.patient.pgr_detection_method_text.@cde.785
tcga_bcr.patient.platelet_qualitative_result.@cde.3104944
tcga_bcr.patient.platelet_result_count.@cde.58304
tcga_bcr.patient.platelet_result_lower_limit.@cde.2003885
tcga_bcr.patient.platelet_result_upper_limit.@cde.2596499
tcga_bcr.patient.pleurodesis_performed.@cde.3646078
tcga_bcr.patient.pleurodesis_performed_90_days.@cde.3646080
tcga_bcr.patient.pln_pos_ihc.@cde.3151829
tcga_bcr.patient.pln_pos_light_micro.@cde.3151830
tcga_bcr.patient.pos_finding_her2_erbb2_other_measurement_scale_text.@cde.3087479
tcga_bcr.patient.pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text.@cde.3131877
tcga_bcr.patient.pos_finding_progesterone_receptor_other_measurement_scale_text.@cde.3086857
tcga_bcr.patient.positive_finding_estrogen_receptor_other_measurement_scale_text.@cde.3086851
tcga_bcr.patient.post_bronchodilator_fev1_fvc_percent.@cde.3302956
tcga_bcr.patient.post_bronchodilator_fev1_percent.@cde.3302948
tcga_bcr.patient.post_op_ablation_embolization_tx.@cde.3172120
tcga_bcr.patient.post_surgical_procedure_assessment_thyroid_gland_carcinoma_status.@cde.3186684
tcga_bcr.patient.postoperative_rx_tx.@cde.3397567
tcga_bcr.patient.postoperative_tx_list.postoperative_tx.@cde.3913861
tcga_bcr.patient.pre_bronchodilator_fev1_fvc_percent.@cde.3302955
tcga_bcr.patient.pre_bronchodilator_fev1_percent.@cde.3302947
tcga_bcr.patient.pregnancies.@cde.3012512
tcga_bcr.patient.pregnancy_stillbirth_count.@cde.2183304
tcga_bcr.patient.pregnant_at_diagnosis.@cde.2005346
tcga_bcr.patient.preoperative_antiseizure_meds.@cde.3121328
tcga_bcr.patient.preoperative_corticosteroids.@cde.3121323
tcga_bcr.patient.preoperative_pretreatment_cea_level.@cde.2716510
tcga_bcr.patient.presence_of_pathological_nodal_extracapsular_spread.@cde.3108215
tcga_bcr.patient.presence_of_sarcomatoid_features.@cde.2429787
tcga_bcr.patient.primary_lymph_node_presentation_assessment.@cde.2200396
tcga_bcr.patient.primary_neoplasm_focus_type.@cde.3174022
tcga_bcr.patient.primary_neoplasm_melanoma_dx.@cde.3108462
tcga_bcr.patient.primary_occupation.@cde.3259240
tcga_bcr.patient.primary_occupation_other.@cde.5714
tcga_bcr.patient.primary_pathology.age_at_initial_pathologic_diagnosis.@cde.2006657
tcga_bcr.patient.primary_pathology.albumin_result_lower_limit.@cde.2004085
tcga_bcr.patient.primary_pathology.albumin_result_specified_value.@cde.58274
tcga_bcr.patient.primary_pathology.albumin_result_upper_limit.@cde.2004086
tcga_bcr.patient.primary_pathology.aln_pos_ihc.@cde.3151831
tcga_bcr.patient.primary_pathology.aln_pos_light_micro.@cde.3151832
tcga_bcr.patient.primary_pathology.anatomic_neoplasm_subdivision.@cde.3108203
tcga_bcr.patient.primary_pathology.bilateral_diagnosis_timing_type.@cde.3901753
tcga_bcr.patient.primary_pathology.bilirubin_lower_limit.@cde.2718241
tcga_bcr.patient.primary_pathology.bilirubin_upper_limit.@cde.2003891
tcga_bcr.patient.primary_pathology.bone_marrow_biopsy_done.@cde.2180833
tcga_bcr.patient.primary_pathology.bone_marrow_involvement.@cde.2180550
tcga_bcr.patient.primary_pathology.bone_marrow_sample_histology.@cde.3233401
tcga_bcr.patient.primary_pathology.ca_19_9_level.@cde.65302
tcga_bcr.patient.primary_pathology.ca_19_9_level_lower.@cde.3915551
tcga_bcr.patient.primary_pathology.ca_19_9_level_upper.@cde.3915552
tcga_bcr.patient.primary_pathology.child_pugh_classification_grade.@cde.2931791
tcga_bcr.patient.primary_pathology.cholangitis_tissue_evidence.@cde.3916091
tcga_bcr.patient.primary_pathology.columnar_metaplasia_present.@cde.3440218
tcga_bcr.patient.primary_pathology.columnar_mucosa_dysplasia.@cde.3440917
tcga_bcr.patient.primary_pathology.columnar_mucosa_goblet_cell_present.@cde.3440219
tcga_bcr.patient.primary_pathology.contiguous_organ_invaded.@cde.3162817
tcga_bcr.patient.primary_pathology.contiguous_organ_resection_site.@cde.3162811
tcga_bcr.patient.primary_pathology.creatinine_lower_level.@cde.2634934
tcga_bcr.patient.primary_pathology.creatinine_norm_range_lower.@cde.2234697
tcga_bcr.patient.primary_pathology.creatinine_norm_range_upper.@cde.2004064
tcga_bcr.patient.primary_pathology.creatinine_prior_tx.@cde.58318
tcga_bcr.patient.primary_pathology.creatinine_upper_limit.@cde.2183392
tcga_bcr.patient.primary_pathology.creatinine_value_in_mg_dl.@cde.2655822
tcga_bcr.patient.primary_pathology.ct_scan.@cde.3534857
tcga_bcr.patient.primary_pathology.ct_scan_findings.@cde.3151439
tcga_bcr.patient.primary_pathology.cytogenetic_abnormality_list.cytogenetic_abnormality.@cde.2760451
tcga_bcr.patient.primary_pathology.days_to_bilateral_tumor_dx.@cde.3966995
tcga_bcr.patient.primary_pathology.days_to_initial_pathologic_diagnosis.@cde.3008275
tcga_bcr.patient.primary_pathology.days_to_initial_pathologic_diagnosis.@cde.3131740
tcga_bcr.patient.primary_pathology.days_to_sample_procurement.@cde.
tcga_bcr.patient.primary_pathology.days_to_sample_procurement.@cde.3288495
tcga_bcr.patient.primary_pathology.days_to_well_differentiated_liposarcoma_primary_dx.@cde.3523205
tcga_bcr.patient.primary_pathology.days_to_well_differentiated_liposarcoma_resection.@cde.3523210
tcga_bcr.patient.primary_pathology.discontiguous_lesion_count.@cde.3162604
tcga_bcr.patient.primary_pathology.disease_detected_on_screening.@cde.3693064
tcga_bcr.patient.primary_pathology.eastern_cancer_oncology_group.@cde.88
tcga_bcr.patient.primary_pathology.esophageal_tumor_cental_location.@cde.3295805
tcga_bcr.patient.primary_pathology.esophageal_tumor_involvement_sites.esophageal_tumor_involvement_site.@cde.3295806
tcga_bcr.patient.primary_pathology.excess_adrenal_hormone_history_types.excess_adrenal_hormone_diagnosis_method_type.@cde.3646387
tcga_bcr.patient.primary_pathology.excess_adrenal_hormone_history_types.excess_adrenal_hormone_history_type.@cde.3646386
tcga_bcr.patient.primary_pathology.extranocular_nodule_size.@cde.3874294
tcga_bcr.patient.primary_pathology.extranodal_involvement_at_diagnosis.@cde.2952463
tcga_bcr.patient.primary_pathology.extranodal_involvement_sites.extranodal_involvement_site.@cde.3288482
tcga_bcr.patient.primary_pathology.extranodal_involvment_site_other.@cde.3234303
tcga_bcr.patient.primary_pathology.extranodal_sites_involvement_number.@cde.3233242
tcga_bcr.patient.primary_pathology.extrascleral_extension.@cde.3874292
tcga_bcr.patient.primary_pathology.extravascular_matrix_patterns.@cde.3874271
tcga_bcr.patient.primary_pathology.fetoprotein_outcome_lower_limit.@cde.3171861
tcga_bcr.patient.primary_pathology.fetoprotein_outcome_upper_limit.@cde.2932064
tcga_bcr.patient.primary_pathology.fetoprotein_outcome_value.@cde.2932074
tcga_bcr.patient.primary_pathology.fibrosis_ishak_score.@cde.3182621
tcga_bcr.patient.primary_pathology.first_treatment_success.@cde.4030393
tcga_bcr.patient.primary_pathology.follicular_percent.@cde.3232840
tcga_bcr.patient.primary_pathology.gene_expression_profile_list.gene_expression_profile.@cde.3870395
tcga_bcr.patient.primary_pathology.germline_genotype_testing_report.germline_genotype_test_categories.max.@cde.3121628
tcga_bcr.patient.primary_pathology.germline_genotype_testing_report.germline_genotype_test_categories.nf1.@cde.3121628
tcga_bcr.patient.primary_pathology.germline_genotype_testing_report.germline_genotype_test_categories.nf1_clinical_diagnosis.@cde.3121628
tcga_bcr.patient.primary_pathology.germline_genotype_testing_report.germline_genotype_test_categories.ret.@cde.3121628
tcga_bcr.patient.primary_pathology.germline_genotype_testing_report.germline_genotype_test_categories.sdha.@cde.3121628
tcga_bcr.patient.primary_pathology.germline_genotype_testing_report.germline_genotype_test_categories.sdhaf2_sdh5.@cde.3121628
tcga_bcr.patient.primary_pathology.germline_genotype_testing_report.germline_genotype_test_categories.sdhb.@cde.3121628
tcga_bcr.patient.primary_pathology.germline_genotype_testing_report.germline_genotype_test_categories.sdhc.@cde.3121628
tcga_bcr.patient.primary_pathology.germline_genotype_testing_report.germline_genotype_test_categories.sdhd.@cde.3121628
tcga_bcr.patient.primary_pathology.germline_genotype_testing_report.germline_genotype_test_categories.tmem127.@cde.3121628
tcga_bcr.patient.primary_pathology.germline_genotype_testing_report.germline_genotype_test_categories.vhl.@cde.3121628
tcga_bcr.patient.primary_pathology.germline_genotype_testing_report.germline_testing_performed.@cde.3121565
tcga_bcr.patient.primary_pathology.histological_type.@cde.3081934
tcga_bcr.patient.primary_pathology.histological_type_list.histological_type.@cde.3081934
tcga_bcr.patient.primary_pathology.histological_type_other.@cde.3124492
tcga_bcr.patient.primary_pathology.histology_list.histology.histological_percentage.@cde.3729998
tcga_bcr.patient.primary_pathology.histology_list.histology.histological_type.@cde.3081934
tcga_bcr.patient.primary_pathology.history_myasthenia_gravis.@cde.3950458
tcga_bcr.patient.primary_pathology.history_prior_surgery_type_other.@cde.3121814
tcga_bcr.patient.primary_pathology.init_pathology_dx_method_other.@cde.2757948
tcga_bcr.patient.primary_pathology.initial_pathologic_diagnosis_method.@cde.2757941
tcga_bcr.patient.primary_pathology.inter_norm_ratio_lower_limit.@cde.2799755
tcga_bcr.patient.primary_pathology.intern_norm_ratio_upper_limit.@cde.3171875
tcga_bcr.patient.primary_pathology.intratubular_germ_cell_neoplasm.@cde.3901770
tcga_bcr.patient.primary_pathology.karnofsky_performance_score.@cde.2003853
tcga_bcr.patient.primary_pathology.laterality.@cde.827
tcga_bcr.patient.primary_pathology.leiomyosarcoma_histologic_subtype.@cde.2831122
tcga_bcr.patient.primary_pathology.leiomyosarcoma_major_vessel_involvement.@cde.3243330
tcga_bcr.patient.primary_pathology.local_disease_recurrence.@cde.62652
tcga_bcr.patient.primary_pathology.lymph_node_examined_count.@cde.3
tcga_bcr.patient.primary_pathology.lymph_node_involvement_sites.lymph_node_involvement_site.@cde.2180591
tcga_bcr.patient.primary_pathology.lymph_node_metastasis_radiographic_evidence.@cde.3440228
tcga_bcr.patient.primary_pathology.lymphovascular_invasion_present.@cde.64727
tcga_bcr.patient.primary_pathology.margin_status.@cde.3114007
tcga_bcr.patient.primary_pathology.maximum_tumor_bulk_anatomic_site.@cde.3639616
tcga_bcr.patient.primary_pathology.maximum_tumor_dimension.@cde.64215
tcga_bcr.patient.primary_pathology.mesothelioma_detection_method.@cde.3629988
tcga_bcr.patient.primary_pathology.metastatic_diagnosis.@cde.65384
tcga_bcr.patient.primary_pathology.metastatic_neoplasm_confirmed_diagnosis_method_names.metastatic_neoplasm_confirmed_diagnosis_method_name.@cde.3178364
tcga_bcr.patient.primary_pathology.metastatic_neoplasm_confirmed_diagnosis_method_names.metastatic_neoplasm_confirmed_diagnosis_method_text.@cde.3178376
tcga_bcr.patient.primary_pathology.metastatic_neoplasm_initial_diagnosis_anatomic_sites.distant_metastasis_anatomic_site.@cde.2961431
tcga_bcr.patient.primary_pathology.metastatic_neoplasm_initial_diagnosis_anatomic_sites.metastatic_neoplasm_initial_diagnosis_anatomic_site.@cde.2967298
tcga_bcr.patient.primary_pathology.metastatic_site_at_diagnosis.@cde.3124499
tcga_bcr.patient.primary_pathology.metastatic_site_at_diagnosis_other.@cde.3124503
tcga_bcr.patient.primary_pathology.metastatic_site_list.metastatic_site.@cde.62835
tcga_bcr.patient.primary_pathology.microvascular_density_mvd.@cde.3874272
tcga_bcr.patient.primary_pathology.mitoses_count.@cde.3646391
tcga_bcr.patient.primary_pathology.mitotic_count.@cde.3227319
tcga_bcr.patient.primary_pathology.molecular_test_result_list.molecular_test_result.@cde.3953322
tcga_bcr.patient.primary_pathology.neoplasm_histologic_grade.@cde.2785839
tcga_bcr.patient.primary_pathology.number_of_lymphnodes_positive_by_he.@cde.3086388
tcga_bcr.patient.primary_pathology.number_of_lymphnodes_positive_by_ihc.@cde.3086383
tcga_bcr.patient.primary_pathology.other_contiguous_organ_resection_site.@cde.3162812
tcga_bcr.patient.primary_pathology.other_metastatic_site.@cde.3135371
tcga_bcr.patient.primary_pathology.outside_adrenal.@cde.3693063
tcga_bcr.patient.primary_pathology.pathologic_tumor_burden.@cde.3162641
tcga_bcr.patient.primary_pathology.pct_tumor_invasion.@cde.3104403
tcga_bcr.patient.primary_pathology.perineural_invasion_present.@cde.64181
tcga_bcr.patient.primary_pathology.peritoneal_wash.@cde.61384
tcga_bcr.patient.primary_pathology.pet_ct_standardized_values.@cde.3133999
tcga_bcr.patient.primary_pathology.planned_surgery_status.@cde.3440231
tcga_bcr.patient.primary_pathology.platelet_result_count.@cde.58304
tcga_bcr.patient.primary_pathology.platelet_result_lower_limit.@cde.2003885
tcga_bcr.patient.primary_pathology.platelet_result_upper_limit.@cde.2596499
tcga_bcr.patient.primary_pathology.pln_pos_ihc.@cde.3151829
tcga_bcr.patient.primary_pathology.pln_pos_light_micro.@cde.3151830
tcga_bcr.patient.primary_pathology.pos_lymph_node_location_other.@cde.3151522
tcga_bcr.patient.primary_pathology.pos_lymph_node_locations.pos_lymph_node_location.@cde.3151519
tcga_bcr.patient.primary_pathology.post_orchi_lymph_node_dissection.@cde.3953323
tcga_bcr.patient.primary_pathology.post_orchi_serum_marker_info.days_to_post_orchi_serum_test.@cde.4348007
tcga_bcr.patient.primary_pathology.post_orchi_serum_marker_info.post_orchi_afp.@cde.3901825
tcga_bcr.patient.primary_pathology.post_orchi_serum_marker_info.post_orchi_hcg.@cde.3901824
tcga_bcr.patient.primary_pathology.post_orchi_serum_marker_info.post_orchi_ldh.@cde.3901823
tcga_bcr.patient.primary_pathology.post_orchi_serum_marker_info.post_orchi_lh.@cde.3901836
tcga_bcr.patient.primary_pathology.post_orchi_serum_marker_info.post_orchi_testosterone.@cde.3901839
tcga_bcr.patient.primary_pathology.postoperative_rx_tx.@cde.3397567
tcga_bcr.patient.primary_pathology.pre_orchi_serum_marker_info.days_to_pre_orchi_serum_test.@cde.4348005
tcga_bcr.patient.primary_pathology.pre_orchi_serum_marker_info.pre_orchi_afp.@cde.3901799
tcga_bcr.patient.primary_pathology.pre_orchi_serum_marker_info.pre_orchi_hcg.@cde.3901798
tcga_bcr.patient.primary_pathology.pre_orchi_serum_marker_info.pre_orchi_ldh.@cde.
tcga_bcr.patient.primary_pathology.pre_orchi_serum_marker_info.pre_orchi_lh.@cde.3901800
tcga_bcr.patient.primary_pathology.pre_orchi_serum_marker_info.pre_orchi_testosterone.@cde.3913864
tcga_bcr.patient.primary_pathology.primary_lymph_node_presentation_assessment.@cde.2200396
tcga_bcr.patient.primary_pathology.primary_tumor_lower_uterus_segment.@cde.2775554
tcga_bcr.patient.primary_pathology.prothrombin_time_result_value.@cde.2459694
tcga_bcr.patient.primary_pathology.radiation_therapy.@cde.2005312
tcga_bcr.patient.primary_pathology.radiologic_tumor_burden.@cde.3162636
tcga_bcr.patient.primary_pathology.residual_tumor.@cde.2608702
tcga_bcr.patient.primary_pathology.section_myasthenia_gravis.@cde.3952852
tcga_bcr.patient.primary_pathology.serum_mesothelin_lower_limit.@cde.3629986
tcga_bcr.patient.primary_pathology.serum_mesothelin_prior_tx.@cde.3629985
tcga_bcr.patient.primary_pathology.serum_mesothelin_upper_limit.@cde.3629987
tcga_bcr.patient.primary_pathology.specimen_collection_method_name.@cde.3131309
tcga_bcr.patient.primary_pathology.surgical_approach.@cde.2429840
tcga_bcr.patient.primary_pathology.suv_of_pleura_max.@cde.2716767
tcga_bcr.patient.primary_pathology.synchronous_tumor_histology_list.synchronous_tumor_histology.synchronous_tumor_histology_pct.@cde.3913863
tcga_bcr.patient.primary_pathology.synchronous_tumor_histology_list.synchronous_tumor_histology.synchronous_tumor_histology_type.@cde.3901762
tcga_bcr.patient.primary_pathology.synovial_sarcoma.mpnst_exisiting_plexiform_neurofibroma.@cde.3733551
tcga_bcr.patient.primary_pathology.synovial_sarcoma.mpnst_neurofibromatosis.@cde.3733521
tcga_bcr.patient.primary_pathology.synovial_sarcoma.mpnst_neurofibromatosis_heredity.@cde.3733535
tcga_bcr.patient.primary_pathology.synovial_sarcoma.mpnst_nf1_genetic_testing.@cde.3733556
tcga_bcr.patient.primary_pathology.synovial_sarcoma.mpnst_specific_mutations.@cde.3733558
tcga_bcr.patient.primary_pathology.synovial_sarcoma.ss18_ssx_fusion_status.@cde.3733516
tcga_bcr.patient.primary_pathology.synovial_sarcoma.ss18_ssx_testing_method.@cde.3733517
tcga_bcr.patient.primary_pathology.testis_tumor_macroextent.@cde.3901766
tcga_bcr.patient.primary_pathology.testis_tumor_macroextent_other.@cde.3901768
tcga_bcr.patient.primary_pathology.testis_tumor_microextent.@cde.3901767
tcga_bcr.patient.primary_pathology.total_aor-lnp.@cde.3151827
tcga_bcr.patient.primary_pathology.total_aor_lnr.@cde.3104460
tcga_bcr.patient.primary_pathology.total_bilirubin_upper_limit.@cde.2004060
tcga_bcr.patient.primary_pathology.total_pelv_lnp.@cde.3151828
tcga_bcr.patient.primary_pathology.total_pelv_lnr.@cde.3104458
tcga_bcr.patient.primary_pathology.treatment_prior_to_surgery.@cde.3440232
tcga_bcr.patient.primary_pathology.tumor_basal_diameter.@cde.3870453
tcga_bcr.patient.primary_pathology.tumor_basal_diameter_mx.@cde.3870439
tcga_bcr.patient.primary_pathology.tumor_depth.@cde.3808610
tcga_bcr.patient.primary_pathology.tumor_infiltrating_lymphocytes.@cde.3870441
tcga_bcr.patient.primary_pathology.tumor_infiltrating_macrophages.@cde.3874291
tcga_bcr.patient.primary_pathology.tumor_morphology_list.tumor_morphology.histological_type.@cde.3081934
tcga_bcr.patient.primary_pathology.tumor_morphology_list.tumor_morphology.tumor_morphology_percentage.@cde.3729984
tcga_bcr.patient.primary_pathology.tumor_multifocal.@cde.64356
tcga_bcr.patient.primary_pathology.tumor_necrosis_percent.@cde.2841237
tcga_bcr.patient.primary_pathology.tumor_shape_pathologic_clinical.@cde.3870445
tcga_bcr.patient.primary_pathology.tumor_sizes.tumor_size.pathologic_tumor_depth.@cde.3528040
tcga_bcr.patient.primary_pathology.tumor_sizes.tumor_size.pathologic_tumor_length.@cde.3528034
tcga_bcr.patient.primary_pathology.tumor_sizes.tumor_size.pathologic_tumor_width.@cde.3528041
tcga_bcr.patient.primary_pathology.tumor_sizes.tumor_size.radiologic_tumor_depth.@cde.3528032
tcga_bcr.patient.primary_pathology.tumor_sizes.tumor_size.radiologic_tumor_length.@cde.3528021
tcga_bcr.patient.primary_pathology.tumor_sizes.tumor_size.radiologic_tumor_width.@cde.3528033
tcga_bcr.patient.primary_pathology.tumor_thickness.@cde.2479403
tcga_bcr.patient.primary_pathology.tumor_thickness_measurement.@cde.3870440
tcga_bcr.patient.primary_pathology.tumor_tissue_site.@cde.3427536
tcga_bcr.patient.primary_pathology.tumor_tissue_site_list.tumor_tissue_site.@cde.3427536
tcga_bcr.patient.primary_pathology.tumor_tissue_site_other.@cde.2584114
tcga_bcr.patient.primary_pathology.tumor_tissue_sites.tumor_tissue_site.@cde.3427536
tcga_bcr.patient.primary_pathology.tumor_total_necrosis_percent.@cde.3300612
tcga_bcr.patient.primary_pathology.vascular_tumor_cell_type.@cde.3168001
tcga_bcr.patient.primary_pathology.weiss_assessment_report.weiss_assessment_categories.atypical_mitotic_figures.@cde.3648743
tcga_bcr.patient.primary_pathology.weiss_assessment_report.weiss_assessment_categories.cytoplasm_presence_less_than_equal_25_percent.@cde.3648743
tcga_bcr.patient.primary_pathology.weiss_assessment_report.weiss_assessment_categories.diffuse_architecture.@cde.3648743
tcga_bcr.patient.primary_pathology.weiss_assessment_report.weiss_assessment_categories.invasion_of_tumor_capsule.@cde.3648743
tcga_bcr.patient.primary_pathology.weiss_assessment_report.weiss_assessment_categories.mitotic_rate.@cde.3648743
tcga_bcr.patient.primary_pathology.weiss_assessment_report.weiss_assessment_categories.necrosis.@cde.3648743
tcga_bcr.patient.primary_pathology.weiss_assessment_report.weiss_assessment_categories.nuclear_grade_III_IV.@cde.3648743
tcga_bcr.patient.primary_pathology.weiss_assessment_report.weiss_assessment_categories.sinusoid_invasion.@cde.3648743
tcga_bcr.patient.primary_pathology.weiss_assessment_report.weiss_assessment_categories.weiss_venous_invasion.@cde.3648743
tcga_bcr.patient.primary_pathology.weiss_assessment_report.weiss_score.@cde.3648744
tcga_bcr.patient.primary_pathology.well_differentiated_liposarcoma_primary_dx.@cde.3162681
tcga_bcr.patient.primary_pathology.year_of_initial_pathologic_diagnosis.@cde.2896960
tcga_bcr.patient.primary_therapy_outcome_success.@cde.2786727
tcga_bcr.patient.primary_thyroid_gland_neoplasm_location_anatomic_site.@cde.3186750
tcga_bcr.patient.prior_glioma.@cde.2786111
tcga_bcr.patient.prior_hematologic_disorder_diagnosis_indicator.@cde.3120971
tcga_bcr.patient.prior_radiation_therapy.@cde.944
tcga_bcr.patient.prior_systemic_therapy.@cde.64176
tcga_bcr.patient.prior_systemic_therapy_types.prior_systemic_therapy_type.@cde.3119700
tcga_bcr.patient.prior_tamoxifen_administered_usage_category.@cde.3104234
tcga_bcr.patient.progesterone_receptor_level_cell_percent_category.@cde.3128342
tcga_bcr.patient.prothrombin_time_result_value.@cde.2459694
tcga_bcr.patient.pulmonary_function_test_performed.@cde.2556486
tcga_bcr.patient.race_list.race.@cde.2192199
tcga_bcr.patient.radiation_therapy.@cde.2005312
tcga_bcr.patient.radiation_therapy_administered_dose_text.@cde.3232933
tcga_bcr.patient.radiation_therapy_administered_preparation_technique_text.@cde.3232960
tcga_bcr.patient.radiation_therapy_to_primary.@cde.3162807
tcga_bcr.patient.radiations.radiation.anatomic_treatment_site.@cde.2793522
tcga_bcr.patient.radiations.radiation.bcr_radiation_uuid.@cde.
tcga_bcr.patient.radiations.radiation.course_number.@cde.2732184
tcga_bcr.patient.radiations.radiation.day_of_form_completion.@cde.2975716
tcga_bcr.patient.radiations.radiation.days_to_radiation_therapy_end.@cde.3008333
tcga_bcr.patient.radiations.radiation.days_to_radiation_therapy_start.@cde.3008313
tcga_bcr.patient.radiations.radiation.measure_of_response.@cde.2857291
tcga_bcr.patient.radiations.radiation.month_of_form_completion.@cde.2975718
tcga_bcr.patient.radiations.radiation.numfractions.@cde.61465
tcga_bcr.patient.radiations.radiation.radiation_dosage.@cde.2721441
tcga_bcr.patient.radiations.radiation.radiation_treatment_ongoing.@cde.2842745
tcga_bcr.patient.radiations.radiation.radiation_type.@cde.2842944
tcga_bcr.patient.radiations.radiation.radiation_type_notes.@cde.2195477
tcga_bcr.patient.radiations.radiation.regimen_indication.@cde.2793511
tcga_bcr.patient.radiations.radiation.regimen_indication_notes.@cde.2793516
tcga_bcr.patient.radiations.radiation.units.@cde.61446
tcga_bcr.patient.radiations.radiation.year_of_form_completion.@cde.2975720
tcga_bcr.patient.radiosensitizing_agent_administered_indicator.@cde.3232932
tcga_bcr.patient.ras_family_gene_genotyping_outcome_lab_results_text.@cde.3179266
tcga_bcr.patient.reflux_history.@cde.3203079
tcga_bcr.patient.relation_testicular_cancer_list.relation_testicular_cancer.@cde.3901751
tcga_bcr.patient.relative_cancer_types.relative_cancer_type.@cde.3457764
tcga_bcr.patient.relative_family_cancer_history.@cde.2691192
tcga_bcr.patient.residual_tumor.@cde.2608702
tcga_bcr.patient.ret_ptc_rearrangement_genotyping_outcome_lab_results_text.@cde.3179271
tcga_bcr.patient.seizure_history.@cde.3121333
tcga_bcr.patient.sensory_changes.@cde.3121365
tcga_bcr.patient.serum_calcium_result.@cde.3113470
tcga_bcr.patient.sites_of_primary_melanomas.primary_melanoma_at_diagnosis_count.@cde.3427429
tcga_bcr.patient.sites_of_primary_melanomas.primary_tumor_multiple_present_ind.@cde.64186
tcga_bcr.patient.sites_of_primary_melanomas.site.primary_anatomic_site_count.@cde.3427609
tcga_bcr.patient.sites_of_primary_melanomas.site.tumor_tissue_site.@cde.3427536
tcga_bcr.patient.sites_of_primary_melanomas.site.tumor_tissue_site_other.@cde.2584114
tcga_bcr.patient.source_of_patient_death_reason.@cde.2390921
tcga_bcr.patient.specimen_collection_method_name.@cde.3131309
tcga_bcr.patient.stage_event.ann_arbor.b_symptoms.@cde.2902402
tcga_bcr.patient.stage_event.ann_arbor.extranodal_involvement.@cde.3364582
tcga_bcr.patient.stage_event.clinical_stage.@cde.3065862
tcga_bcr.patient.stage_event.clinical_stage.@cde.3225684
tcga_bcr.patient.stage_event.clinical_stage.@cde.3440332
tcga_bcr.patient.stage_event.gleason_grading.gleason_score.@cde.2534619
tcga_bcr.patient.stage_event.gleason_grading.primary_pattern.@cde.2534617
tcga_bcr.patient.stage_event.gleason_grading.secondary_pattern.@cde.2534618
tcga_bcr.patient.stage_event.gleason_grading.tertiary_pattern.@cde.2783875
tcga_bcr.patient.stage_event.igcccg_stage.@cde.3901822
tcga_bcr.patient.stage_event.masaoka_stage.@cde.3952848
tcga_bcr.patient.stage_event.pathologic_stage.@cde.3203222
tcga_bcr.patient.stage_event.pathologic_stage.@cde.5615605
tcga_bcr.patient.stage_event.psa.days_to_psa.@cde.3414608
tcga_bcr.patient.stage_event.psa.psa_value.@cde.3351903
tcga_bcr.patient.stage_event.serum_markers.@cde.3901772
tcga_bcr.patient.stage_event.system_version.@cde.2722309
tcga_bcr.patient.stage_event.system_version.@cde.3114049
tcga_bcr.patient.stage_event.tnm_categories.clinical_categories.clinical_M.@cde.3440331
tcga_bcr.patient.stage_event.tnm_categories.clinical_categories.clinical_N.@cde.3440330
tcga_bcr.patient.stage_event.tnm_categories.clinical_categories.clinical_T.@cde.3440328
tcga_bcr.patient.stage_event.tnm_categories.pathologic_categories.pathologic_M.@cde.3045439
tcga_bcr.patient.stage_event.tnm_categories.pathologic_categories.pathologic_N.@cde.3203106
tcga_bcr.patient.stage_event.tnm_categories.pathologic_categories.pathologic_T.@cde.3045435
tcga_bcr.patient.standardized_uptake_value_cervix_uteri_assessment_measurement.@cde.3151615
tcga_bcr.patient.state_province_of_procurement.@cde.2179603
tcga_bcr.patient.steroid_therapy_administered.@cde.2459014
tcga_bcr.patient.stopped_smoking_year.@cde.2228610
tcga_bcr.patient.submitted_tumor_location.@cde.3427526
tcga_bcr.patient.supratentorial_localization.@cde.3133891
tcga_bcr.patient.surgery_performed_type.@cde.3121809
tcga_bcr.patient.surgical_approach.@cde.2429840
tcga_bcr.patient.surgical_procedure_purpose_other_text.@cde.3020338
tcga_bcr.patient.synchronous_colon_cancer_present.@cde.2185953
tcga_bcr.patient.tests_performed.b_lymphocyte_genotyping_method.@cde.3233449
tcga_bcr.patient.tests_performed.ebv_positive_malignant_cells_percent.@cde.3233649
tcga_bcr.patient.tests_performed.ebv_status_malignant_cells_method.@cde.3233656
tcga_bcr.patient.tests_performed.epstein_barr_viral_status.@cde.2003961
tcga_bcr.patient.tests_performed.genetic_abnormalities.genetic_abnormality_testing_result.genetic_abnormality_method.@cde.3234684
tcga_bcr.patient.tests_performed.genetic_abnormalities.genetic_abnormality_testing_result.genetic_abnormality_method_other.@cde.4459355
tcga_bcr.patient.tests_performed.genetic_abnormalities.genetic_abnormality_testing_result.genetic_abnormality_results.@cde.3234680
tcga_bcr.patient.tests_performed.genetic_abnormalities.genetic_abnormality_testing_result.genetic_abnormality_results_other.@cde.4459354
tcga_bcr.patient.tests_performed.genetic_abnormalities.genetic_abnormality_testing_result.genetic_abnormality_tested.@cde.3234675
tcga_bcr.patient.tests_performed.genetic_abnormalities.genetic_abnormality_testing_result.genetic_abnormality_tested_other.@cde.3234685
tcga_bcr.patient.tests_performed.genetic_testing_results.genetic_testing_result.immunophenotypic_analysis_method.@cde.64540
tcga_bcr.patient.tests_performed.genetic_testing_results.genetic_testing_result.immunophenotypic_analysis_results.@cde.3234626
tcga_bcr.patient.tests_performed.genetic_testing_results.genetic_testing_result.immunophenotypic_analysis_tested.@cde.3234614
tcga_bcr.patient.tests_performed.genetic_testing_results.genetic_testing_result.immunophenotypic_analysis_tested_other.@cde.2516429
tcga_bcr.patient.tests_performed.igh_genotype_results.@cde.3233560
tcga_bcr.patient.tests_performed.igk_genotype_results.@cde.3233565
tcga_bcr.patient.tests_performed.immunophenotypic_analysis_method.@cde.64540
tcga_bcr.patient.tests_performed.ldh_level.@cde.2798766
tcga_bcr.patient.tests_performed.ldh_norm_range_upper.@cde.2597015
tcga_bcr.patient.tests_performed.mib1_positive_percentage_range.@cde.3233414
tcga_bcr.patient.therapeutic_mitotane_levels_achieved.@cde.3646378
tcga_bcr.patient.therapeutic_mitotane_lvl_macroscopic_residual.@cde.3646380
tcga_bcr.patient.therapeutic_mitotane_lvl_progression.@cde.3646382
tcga_bcr.patient.therapeutic_mitotane_lvl_recurrence.@cde.3646379
tcga_bcr.patient.tissue_prospective_collection_indicator.@cde.3088492
tcga_bcr.patient.tissue_retrospective_collection_indicator.@cde.3088528
tcga_bcr.patient.tissue_source_site.@cde.
tcga_bcr.patient.tobacco_smoking_history.@cde.2181650
tcga_bcr.patient.total_aor-lnp.@cde.3151827
tcga_bcr.patient.total_aor_lnr.@cde.3104460
tcga_bcr.patient.total_bilirubin_upper_limit.@cde.2004060
tcga_bcr.patient.total_dose_units.@cde.3088785
tcga_bcr.patient.total_number_of_pregnancies.@cde.2180638
tcga_bcr.patient.total_pelv_lnp.@cde.3151828
tcga_bcr.patient.total_pelv_lnr.@cde.3104458
tcga_bcr.patient.treatment.concurrent_rx_tx_info.chemotherapy_negation_radiation_therapy_concurrent_administered_text.@cde.3151824
tcga_bcr.patient.treatment.concurrent_rx_tx_info.chemotherapy_negation_radiation_therapy_concurrent_not_administered_reason.@cde.3151120
tcga_bcr.patient.treatment.concurrent_rx_tx_info.concurrent_chemotherapy_indicator.@cde.2539220
tcga_bcr.patient.treatment.concurrent_rx_tx_info.concurrent_rx_tx.agent_total_dose_count.@cde.2180805
tcga_bcr.patient.treatment.concurrent_rx_tx_info.concurrent_rx_tx.chemotherapy_regimen_type.@cde.2007212
tcga_bcr.patient.treatment.concurrent_rx_tx_info.concurrent_rx_tx.concurrent_chemotherapy_dose.@cde.3166172
tcga_bcr.patient.treatment.concurrent_rx_tx_info.concurrent_rx_tx.dose_frequency_text.@cde.2179580
tcga_bcr.patient.treatment.concurrent_rx_tx_info.concurrent_rx_tx.other_chemotherapy_agent_administration_specify.@cde.2426129
tcga_bcr.patient.treatment.postoperative_rx_tx.@cde.3397567
tcga_bcr.patient.treatment.radiation_therapy.@cde.2005312
tcga_bcr.patient.treatment.radiation_therapy_info.brachytherapy_first_reference_point_administered_total_dose.@cde.3151100
tcga_bcr.patient.treatment.radiation_therapy_info.brachytherapy_method_other_specify_text.@cde.3150976
tcga_bcr.patient.treatment.radiation_therapy_info.brachytherapy_method_type.@cde.2966127
tcga_bcr.patient.treatment.radiation_therapy_info.external_beam_radiation_therapy_administered_paraaortic_region_lymph_node_dose.@cde.3151106
tcga_bcr.patient.treatment.radiation_therapy_info.radiation_therapy_not_administered_reason.@cde.2733266
tcga_bcr.patient.treatment.radiation_therapy_info.radiation_therapy_not_administered_specify.@cde.2733267
tcga_bcr.patient.treatment.radiation_therapy_info.radiation_type_notes.@cde.2195477
tcga_bcr.patient.treatment.radiation_therapy_info.rt_administered_type.@cde.61468
tcga_bcr.patient.treatment.radiation_therapy_info.rt_pelvis_administered_total_dose.@cde.3006
tcga_bcr.patient.treatments.treatment.agent.@cde.4285089
tcga_bcr.patient.treatments.treatment.bcr_treatment_uuid.@cde.
tcga_bcr.patient.treatments.treatment.chemotherapy_end.@cde.2188260
tcga_bcr.patient.treatments.treatment.day_of_form_completion.@cde.2975716
tcga_bcr.patient.treatments.treatment.days_to_treatment_end.@cde.5102431
tcga_bcr.patient.treatments.treatment.days_to_treatment_start.@cde.5102411
tcga_bcr.patient.treatments.treatment.extranodal_radiation_field_list.extranodal_radiation_field.@cde.2416537
tcga_bcr.patient.treatments.treatment.measure_of_response.@cde.2857291
tcga_bcr.patient.treatments.treatment.month_of_form_completion.@cde.2975718
tcga_bcr.patient.treatments.treatment.number_cycles.@cde.62590
tcga_bcr.patient.treatments.treatment.pharm_regimen.@cde.3366758
tcga_bcr.patient.treatments.treatment.pharm_regimen_other.@cde.3366930
tcga_bcr.patient.treatments.treatment.radiation_therapy_end.@cde.4618471
tcga_bcr.patient.treatments.treatment.radiation_therapy_total_dosage.@cde.36
tcga_bcr.patient.treatments.treatment.regimen_indication.@cde.2793511
tcga_bcr.patient.treatments.treatment.specify_single_agent_therapy.@cde.3590022
tcga_bcr.patient.treatments.treatment.targeted_nodal_region_list.targeted_nodal_region.@cde.3762198
tcga_bcr.patient.treatments.treatment.targeted_nodal_region_other.@cde.62999
tcga_bcr.patient.treatments.treatment.treatment_type.@cde.5102381
tcga_bcr.patient.treatments.treatment.treatment_type_other.@cde.5544691
tcga_bcr.patient.treatments.treatment.year_of_form_completion.@cde.2975720
tcga_bcr.patient.tumor_levels.tumor_level.@cde.3348845
tcga_bcr.patient.tumor_location.@cde.3139375
tcga_bcr.patient.tumor_residual_disease.@cde.2785858
tcga_bcr.patient.tumor_response_cdus_type.@cde.2178525
tcga_bcr.patient.tumor_tissue_site.@cde.3427536
tcga_bcr.patient.tumor_tissue_site_other.@cde.2584114
tcga_bcr.patient.tumor_type.@cde.3104937
tcga_bcr.patient.tumor_type.@cde.3288124
tcga_bcr.patient.undescended_testis_corrected.@cde.3896672
tcga_bcr.patient.undescended_testis_corrected_age.@cde.3896673
tcga_bcr.patient.undescended_testis_method_left.@cde.4340449
tcga_bcr.patient.undescended_testis_method_right.@cde.4340450
tcga_bcr.patient.vascular_tumor_cell_type.@cde.3168001
tcga_bcr.patient.venous_invasion.@cde.64358
tcga_bcr.patient.viral_hepatitis_serologies.viral_hepatitis_serology.@cde.4395982
tcga_bcr.patient.visual_changes.@cde.3121359
tcga_bcr.patient.vital_status.@cde.5
tcga_bcr.patient.weight.@cde.651
tcga_bcr.patient.white_cell_count_result.@cde.3104948
tcga_bcr.patient.year_of_form_completion.@cde.2975720
tcga_bcr.patient.year_of_initial_pathologic_diagnosis.@cde.2896960
tcga_bcr.patient.year_of_tobacco_smoking_onset.@cde.2228604
tcga_bcr.patient.zone_of_origin.@cde.65104
